[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 635
1. Paolo Martorano P, Falzetti G, Pelaia P: Bispectral index and spectral entropy in neuroanesthesia. J Neurosurg Anesthesiol; 2006 Jul;18(3):205-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This open-label prospective study was designed to evaluate SpEn and BIS in 20 patients undergoing elective supratentorial neurosurgery with craniotomy and resection of brain tumors.
  • [MeSH-minor] Adolescent. Adult. Aged. Anesthesia, Intravenous. Anesthetics, Intravenous. Cerebral Revascularization. Entropy. Female. Hemodynamics / physiology. Humans. Infusions, Intravenous. Male. Meningioma / surgery. Middle Aged. Monitoring, Intraoperative. Propofol. Sufentanil. Supratentorial Neoplasms / surgery. Wakefulness

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. PROPOFOL .
  • Hazardous Substances Data Bank. SUFENTANIL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg Anesthesiol. 2007 Jan;19(1):65-6 [17198105.001]
  • (PMID = 16799349.001).
  • [ISSN] 0898-4921
  • [Journal-full-title] Journal of neurosurgical anesthesiology
  • [ISO-abbreviation] J Neurosurg Anesthesiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anesthetics, Intravenous; AFE2YW0IIZ / Sufentanil; YI7VU623SF / Propofol
  •  go-up   go-down


2. Jolapara M, Kesavadas C, Radhakrishnan VV, Thomas B, Gupta AK, Bodhey N, Patro S, Saini J, George U, Sarma PS: Role of diffusion tensor imaging in differentiating subtypes of meningiomas. J Neuroradiol; 2010 Dec;37(5):277-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) are two new imaging techniques that have proved helpful in elucidating the microarchitecture of brain tumors.
  • The aim of the present study was to assess the role of diffusion and diffusion tensor metrics in the identification and classification of meningioma grades and subtypes.
  • METHODS AND MATERIALS: A total of 21 consecutive patients with meningioma were included in this retrospective study, of whom 16 had benign meningiomas (three fibroblastic, 11 transitional/mixed, two meningothelial) and five had atypical meningiomas.
  • [MeSH-major] Diffusion Tensor Imaging. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Anisotropy. Female. Humans. Image Processing, Computer-Assisted. Male. Middle Aged. Retrospective Studies. Statistics, Nonparametric

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20381865.001).
  • [ISSN] 0150-9861
  • [Journal-full-title] Journal of neuroradiology. Journal de neuroradiologie
  • [ISO-abbreviation] J Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  •  go-up   go-down


3. Hsu YY, Yang WS, Lim KE, Liu HL: Vessel size imaging using dual contrast agent injections. J Magn Reson Imaging; 2009 Nov;30(5):1078-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To investigate the feasibility of a vessel size imaging (VSI) technique with separate contrast agent injections for evaluation of the vessel caliber in normal tissues and in brain tumors.
  • Eight patients (four female, four male, 37-77 years old) with brain tumors (three high-grade gliomas, two low-grade gliomas, and three meningiomas) were recruited for clinical study.
  • CONCLUSION: This study suggests that VSI with a dual injection method is a feasible technique for estimating microvascular calibers of normal tissues and brain tumors in clinical scanners.
  • [MeSH-major] Brain Neoplasms / blood supply. Brain Neoplasms / pathology. Contrast Media / pharmacology. Glioma / pathology. Magnetic Resonance Imaging / methods. Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Calibration. Computer Simulation. Diagnostic Imaging / methods. Female. Humans. Image Processing, Computer-Assisted / methods. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19856441.001).
  • [ISSN] 1522-2586
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


Advertisement
4. Giussani C, Pirillo D, Roux FE: Mirror of the soul: a cortical stimulation study on recognition of facial emotions. J Neurosurg; 2010 Mar;112(3):520-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The feasibility and the interest to map them during brain mapping for neurosurgical procedures are discussed.
  • METHODS: After a preoperative neuropsychological evaluation, 18 consecutive patients with right hemispheric lesions (5 metastases, 6 high-grade gliomas, 4 low-grade gliomas, 2 arteriovenous malformations, and 1 malignant meningioma) were tested by intraoperative cortical stimulation while performing a facial emotion recognition task along with sensorimotor and visuospatial tasks.
  • The authors advocate offering a brain mapping of facial emotion recognition to patients with right posterior perisylvian tumors.
  • [MeSH-major] Brain / physiology. Facial Expression. Pattern Recognition, Visual / physiology
  • [MeSH-minor] Adult. Aged. Brain Mapping / methods. Brain Neoplasms / physiopathology. Brain Neoplasms / surgery. Electric Stimulation / methods. Female. Humans. Male. Middle Aged. Neuropsychological Tests. Neurosurgical Procedures. Reproducibility of Results

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19538049.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Curry WT, McDermott MW, Carter BS, Barker FG 2nd: Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg; 2005 Jun;102(6):977-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload.
  • Multivariate analyses revealed that larger-volume centers had lower mortality rates for patients who underwent craniotomy for meningioma (odds ratio [OR] 0.74, 95% confidence interval [CI] 0.59-0.93, p = 0.01).
  • The annual meningioma caseload in the US increased 83% between 1988 and 2000, from 3900 patients/year to 7200 patients/year.
  • Fewer centers hosted one meningioma resection annually, whereas the largest centers had disproportionate increases in their caseloads, indicating a modest centralization of meningioma surgery in the US during this interval.
  • CONCLUSIONS: The mortality and adverse hospital discharge disposition rates were lower when meningioma surgery was performed by high-volume providers.
  • [MeSH-major] Craniotomy / mortality. Meningeal Neoplasms / mortality. Meningeal Neoplasms / surgery. Meningioma / mortality. Meningioma / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Centralized Hospital Services / statistics & numerical data. Cohort Studies. Databases, Factual. Female. Hospital Mortality / trends. Humans. Male. Middle Aged. Multivariate Analysis. Neurosurgery / statistics & numerical data. Postoperative Complications / mortality. Retrospective Studies. Risk Factors. United States / epidemiology

  • Genetic Alliance. consumer health - Meningioma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2005 Jun;102(6):969-70; discussion 970 [16028752.001]
  • (PMID = 16028755.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


6. Xu L, Lin Y, Han JC, Xi ZN, Shen H, Gao PY: Magnetic resonance elastography of brain tumors: preliminary results. Acta Radiol; 2007 Apr;48(3):327-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Magnetic resonance elastography of brain tumors: preliminary results.
  • PURPOSE: To investigate the potential value of magnetic resonance elastography (MRE) in evaluating the consistency of brain tumors.
  • MATERIAL AND METHODS: Six patients with known solid brain tumor underwent brain MRE studies.
  • Consistency of brain tumors was evaluated at surgery.
  • CONCLUSION: MRE could be used as an imaging technique for noninvasive assessment of the consistency of brain tumor in vivo.
  • [MeSH-major] Brain Neoplasms / pathology. Magnetic Resonance Imaging / methods
  • [MeSH-minor] Adolescent. Adult. Female. Hemangiopericytoma / pathology. Humans. Male. Meningioma / pathology. Middle Aged. Neurilemmoma / pathology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Acta Radiol. 2007 Apr;48(3):249 [17453488.001]
  • (PMID = 17453505.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Sweden
  •  go-up   go-down


7. Okamoto K, Furusawa T, Ishikawa K, Sasai K, Tokiguchi S: Focal T2 hyperintensity in the dorsal brain stem in patients with vestibular schwannoma. AJNR Am J Neuroradiol; 2006 Jun-Jul;27(6):1307-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Focal T2 hyperintensity in the dorsal brain stem in patients with vestibular schwannoma.
  • BACKGROUND AND PURPOSE: The vestibular nucleus cannot be visualized on MR imaging, but some patients with vestibular schwannoma show a tiny area of hyperintensity in the dorsal brain stem on T2-weighted images.
  • Surgical and histopathologic diagnosis was vestibular schwannoma (41/53 = 77%), meningioma (7/53 = 13%), epidermoid cyst (3/53 = 6%), glioma with exophytic growth (1/53 = 2%), and chordoma (1/53 = 2%).
  • [MeSH-major] Brain Stem / pathology. Magnetic Resonance Imaging. Neuroma, Acoustic / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Cerebellar Neoplasms / diagnosis. Cerebellar Neoplasms / pathology. Cerebellar Neoplasms / surgery. Cerebellopontine Angle. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16775286.001).
  • [ISSN] 0195-6108
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Mobley BC, Roulston D, Shah GV, Bijwaard KE, McKeever PE: Peripheral primitive neuroectodermal tumor/Ewing's sarcoma of the craniospinal vault: case reports and review. Hum Pathol; 2006 Jul;37(7):845-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An intracranial pPNET that mimicked a meningioma was found in a 21-year-old man presenting with headache and visual disturbances.
  • [MeSH-major] Brain Neoplasms / pathology. Cauda Equina / pathology. Neuroectodermal Tumors, Primitive, Peripheral / pathology. Peripheral Nervous System Neoplasms / pathology. Sarcoma, Ewing / pathology
  • [MeSH-minor] Adult. Antigens, CD / metabolism. Back Pain / etiology. Blotting, Southern. Cell Adhesion Molecules / metabolism. Chromosome Aberrations. Chromosomes, Human, Pair 22 / genetics. Diagnosis, Differential. Headache / etiology. Humans. Male. Meningioma / pathology. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Protein c-fli-1 / genetics. RNA-Binding Protein EWS. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16784984.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules; 0 / EWS-FLI fusion protein; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA-Binding Protein EWS
  • [Number-of-references] 68
  •  go-up   go-down


9. D'Angelo C, Mirijello A, Leggio L, Ferrulli A, Carotenuto V, Icolaro N, Miceli A, D'Angelo V, Gasbarrini G, Addolorato G: State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg; 2008 Feb;108(2):281-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study.
  • OBJECT: The aim in this study was to assess the state and trait types of anxiety as well as current depression before and after surgery in patients affected by brain tumors.
  • METHODS: A total of 72 patients affected by a primary brain tumor were enrolled in the study.
  • RESULTS: Before brain surgery, 62.5% of patients showed state anxiety, 50% of patients showed trait anxiety, and 9.7% of patients showed current depression.
  • CONCLUSIONS: Patients affected by brain tumors frequently experience affective disorders.
  • After brain surgery, a depressive state can develop.
  • [MeSH-major] Anxiety / psychology. Brain Neoplasms / psychology. Depression / psychology
  • [MeSH-minor] Adenoma / psychology. Adenoma / surgery. Adult. Aged. Aged, 80 and over. Cognition Disorders / psychology. Female. Follow-Up Studies. Glioma / psychology. Glioma / surgery. Humans. Longitudinal Studies. Male. Meningioma / psychology. Meningioma / surgery. Mental Status Schedule. Middle Aged. Mood Disorders / psychology. Neuroma, Acoustic / psychology. Neuroma, Acoustic / surgery. Personality Inventory. Pituitary Neoplasms / psychology. Pituitary Neoplasms / surgery. Sex Factors


10. Martínez C, Molina JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Agúndez JA, García-Martín E: Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol; 2010;10:71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.
  • Aiming to identify genetic variations related to the risk of developing brain tumors, we investigated the putative association between common nonsynonymous PON1 polymorphisms and the risk of developing astrocytoma and meningioma.
  • METHODS: Seventy one consecutive patients with brain tumors (43 with astrocytoma grade II/III and 28 with meningioma) with ages ranging 21 to 76 years, and 220 healthy controls subjects were analyzed for the frequency of the nonsynonymous PON1 genotypes L55M rs854560 and Q192R rs662.
  • All participants were adult Caucasian individuals recruited in the central area of Spain.
  • RESULTS: The frequencies of the PON1 genotypes and allelic variants of the polymorphisms PON1 L55M and PON1 Q192R did not differ significantly between patients with astrocytoma and meningioma and controls.
  • The minor allele frequencies were as follows: PON1 55L, 0.398, 0.328 and 0.286 for patients with astrocytoma, meningioma and control individuals, respectively; PON1 192R, 0.341, 0.362 and 0.302 for patients with astrocytoma, meningioma and control individuals, respectively.
  • Haplotype association analyses did not identify any significant association with the risk of developing astrocytoma or meningioma.
  • CONCLUSIONS: Common nonsynonymous PON1 polymorphisms are not related with the risk of developing astrocytoma and meningioma.
  • [MeSH-major] Aryldialkylphosphatase / genetics. Astrocytoma / genetics. Brain Neoplasms / genetics. Meningeal Neoplasms / genetics. Meningioma / genetics
  • [MeSH-minor] Adult. Aged. Female. Genetic Predisposition to Disease. Genotype. Humans. Male. Middle Aged. Polymerase Chain Reaction. Polymorphism, Single Nucleotide. Young Adult

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Ind Med. 1998 Sep;34(3):252-60 [9698994.001]
  • [Cites] Atherosclerosis. 1998 Aug;139(2):341-9 [9712341.001]
  • [Cites] Biochem Pharmacol. 1998 Sep 1;56(5):547-51 [9783722.001]
  • [Cites] Int J Cancer. 2005 Jan 1;113(1):116-25 [15386358.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Environ Health Perspect. 2005 May;113(5):546-51 [15866761.001]
  • [Cites] Environ Health Perspect. 2005 Jul;113(7):909-13 [16002382.001]
  • [Cites] Liver Int. 2005 Oct;25(5):935-9 [16162149.001]
  • [Cites] Toxicology. 2005 Nov 15;215(3):182-90 [16102884.001]
  • [Cites] Occup Environ Med. 2005 Nov;62(11):786-92 [16234405.001]
  • [Cites] World J Gastroenterol. 2006 Jan 28;12(4):615-20 [16489678.001]
  • [Cites] Acta Neurol Scand. 2006 May;113(5):322-6 [16629768.001]
  • [Cites] Oncol Rep. 2006 Jun;15(6):1513-6 [16685388.001]
  • [Cites] Pharmacogenomics. 2006 Jul;7(5):711-8 [16886896.001]
  • [Cites] Cell Biochem Funct. 2006 Sep-Oct;24(5):455-60 [16142697.001]
  • [Cites] J Agric Saf Health. 2006 Nov;12(4):255-74 [17131948.001]
  • [Cites] Drug Metab Dispos. 2007 Feb;35(2):315-20 [17132760.001]
  • [Cites] Occup Environ Med. 2007 Aug;64(8):509-14 [17537748.001]
  • [Cites] Am J Hum Genet. 2007 Sep;81(3):559-75 [17701901.001]
  • [Cites] J Toxicol Environ Health B Crit Rev. 2007 Jan-Mar;10(1-2):81-99 [18074305.001]
  • [Cites] Pharmacogenet Genomics. 2008 Jan;18(1):37-43 [18216720.001]
  • [Cites] Am J Epidemiol. 2008 Apr 15;167(8):976-85 [18299277.001]
  • [Cites] Clin Chem. 2008 Aug;54(8):1390-4 [18664443.001]
  • [Cites] Curr Drug Metab. 2008 Jul;9(6):520-31 [18680472.001]
  • [Cites] Neuro Oncol. 2008 Oct;10(5):709-15 [18682580.001]
  • [Cites] Psychiatr Genet. 2008 Dec;18(6):289-94 [19018234.001]
  • [Cites] Toxicol Appl Pharmacol. 2009 Apr 15;236(2):142-53 [19371602.001]
  • [Cites] Cell Biochem Funct. 2009 Dec;27(8):558-67 [19902425.001]
  • [Cites] Environ Health Perspect. 2010 Jan;118(1):144-9 [20056567.001]
  • [Cites] Adv Exp Med Biol. 2010;660:47-60 [20221870.001]
  • [Cites] Eur J Neurol. 2010 Jun 1;17(6):879-81 [20050883.001]
  • [Cites] Chem Biol Interact. 2010 Sep 6;187(1-3):355-61 [20338154.001]
  • [Cites] Neuromolecular Med. 2010 Sep;12(3):217-23 [19826962.001]
  • [Cites] Cell Mol Biol (Noisy-le-grand). 1999 Feb;45(1):15-23 [10099836.001]
  • [Cites] Pharmacogenetics. 2000 Dec;10(9):767-79 [11191881.001]
  • [Cites] J Lipid Res. 2001 Apr;42(4):528-35 [11290824.001]
  • [Cites] Toxicol Appl Pharmacol. 2001 May 15;173(1):1-6 [11350209.001]
  • [Cites] Carcinogenesis. 2001 Aug;22(8):1323-6 [11470765.001]
  • [Cites] Environ Health Perspect. 2001 Sep;109(9):909-13 [11673119.001]
  • [Cites] Ann Diagn Pathol. 2002 Feb;6(1):44-8 [11842378.001]
  • [Cites] Curr Opin Lipidol. 2002 Aug;13(4):357-62 [12151850.001]
  • [Cites] Am J Ind Med. 2002 Sep;42(3):214-27 [12210690.001]
  • [Cites] Cancer Causes Control. 2003 Mar;14(2):139-50 [12749719.001]
  • [Cites] Br J Neurosurg. 2003 Apr;17(2):182-4 [12820764.001]
  • [Cites] Am J Hum Genet. 2003 Nov;73(5):1162-9 [14574645.001]
  • [Cites] J Mol Med (Berl). 2003 Dec;81(12):766-79 [14551701.001]
  • [Cites] J Natl Cancer Inst. 2004 Mar 17;96(6):434-42 [15026468.001]
  • [Cites] Am J Ind Med. 2004 May;45(5):395-407 [15095422.001]
  • [Cites] Curr Drug Metab. 2004 Jun;5(3):211-24 [15180491.001]
  • [Cites] Arch Pathol Lab Med. 1979 Dec;103(13):676-9 [583126.001]
  • [Cites] J Neurol. 1982;227(3):165-9 [6181224.001]
  • [Cites] Indian J Cancer. 1983 Mar;20(1A):86-8 [6873998.001]
  • [Cites] Am J Epidemiol. 1988 Oct;128(4):778-85 [3421243.001]
  • [Cites] Neurologia. 1988 Mar-Apr;3(2):68-70 [2856211.001]
  • [Cites] J Neurosci Nurs. 1992 Oct;24(5):260-4 [1328422.001]
  • [Cites] Am J Hum Genet. 1993 Mar;52(3):598-608 [7916578.001]
  • [Cites] Nat Genet. 1993 Jan;3(1):73-6 [8098250.001]
  • [Cites] Neurosurgery. 1995 Mar;36(3):599-604; discussion 604-5 [7753363.001]
  • [Cites] Cancer Res. 1995 Oct 1;55(19):4237-9 [7671227.001]
  • [Cites] J Neurosurg Sci. 1995 Mar;39(1):27-35 [8568553.001]
  • [Cites] Epidemiol Rev. 1995;17(2):382-414 [8654518.001]
  • [Cites] Curr Opin Lipidol. 1996 Apr;7(2):69-76 [8743898.001]
  • [Cites] Nat Genet. 1996 Nov;14(3):334-6 [8896566.001]
  • [Cites] Environ Health Perspect. 1998 Jun;106 Suppl 3:893-908 [9646054.001]
  • [Cites] Nature. 1998 Jul 16;394(6690):284-7 [9685159.001]
  • (PMID = 20723250.001).
  • [ISSN] 1471-2377
  • [Journal-full-title] BMC neurology
  • [ISO-abbreviation] BMC Neurol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 3.1.8.1 / Aryldialkylphosphatase; EC 3.1.8.1 / PON1 protein, human
  • [Other-IDs] NLM/ PMC2936881
  •  go-up   go-down


11. Lönn S, Ahlbom A, Hall P, Feychting M, Swedish Interphone Study Group: Long-term mobile phone use and brain tumor risk. Am J Epidemiol; 2005 Mar 15;161(6):526-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term mobile phone use and brain tumor risk.
  • The purpose of this population-based, case-control study was to test the hypothesis that long-term mobile phone use increases the risk of brain tumors.
  • The authors identified all cases aged 20-69 years who were diagnosed with glioma or meningioma during 2000-2002 in certain parts of Sweden.
  • Detailed information about mobile phone use was collected from 371 (74%) glioma and 273 (85%) meningioma cases and 674 (71%) controls.
  • For regular mobile phone use, the odds ratio was 0.8 (95% confidence interval: 0.6, 1.0) for glioma and 0.7 (95% confidence interval: 0.5, 0.9) for meningioma.
  • This study includes a large number of long-term mobile phone users, and the authors conclude that the data do not support the hypothesis that mobile phone use is related to an increased risk of glioma or meningioma.
  • [MeSH-major] Brain Neoplasms / etiology. Cell Phones. Glioma / etiology. Meningioma / etiology
  • [MeSH-minor] Adult. Age Distribution. Aged. Case-Control Studies. Confidence Intervals. Female. Humans. Male. Middle Aged. Sex Distribution. Sweden / epidemiology. Time Factors

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Am J Epidemiol. 2005 Sep 15;162(6):600-1; author reply 601 [16107569.001]
  • [CommentIn] Am J Epidemiol. 2005 Sep 15;162(6):599-600; author reply 601 [16107571.001]
  • [CommentIn] Am J Epidemiol. 2005 Sep 15;162(6):599; author reply 601 [16107570.001]
  • (PMID = 15746469.001).
  • [ISSN] 0002-9262
  • [Journal-full-title] American journal of epidemiology
  • [ISO-abbreviation] Am. J. Epidemiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


12. Demir MK, Iplikcioglu AC, Dincer A, Arslan M, Sav A: Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol; 2006 Oct;60(1):48-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the five meningiomas in which a lactate peak was detected, four were in typical cases and only one was in atypical meningioma.
  • [MeSH-major] Brain Chemistry. Brain Neoplasms / diagnosis. Meningeal Neoplasms / chemistry. Meningeal Neoplasms / diagnosis. Meningioma / chemistry. Meningioma / diagnosis
  • [MeSH-minor] Adult. Aged. Diagnosis, Computer-Assisted / methods. Female. Humans. Magnetic Resonance Spectroscopy / methods. Male. Middle Aged. Protons. Reproducibility of Results. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16844335.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


13. Pistolesi S, Boldrini L, Gisfredi S, Ursino S, Alì G, Nuti S, De Ieso K, Pieracci N, Parenti G, Fontanini G: Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas. Cancer Invest; 2007;25(7):555-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas.
  • COX-2 expression was evaluated in intracranial meningiomas, relating this molecule to grade, vasculature, VEGF and brain edema.
  • In conclusion, COX-2 seems to be related to the more aggressive meningiomas and, somehow, to the development of meningioma-associated brain edema.
  • [MeSH-major] Brain Edema / enzymology. Cyclooxygenase 2 / metabolism. Meningeal Neoplasms / enzymology. Meningioma / enzymology
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Microcirculation. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Edema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17952743.001).
  • [ISSN] 1532-4192
  • [Journal-full-title] Cancer investigation
  • [ISO-abbreviation] Cancer Invest.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


14. Schmitz-Feuerhake I, Pflugbeil S, Pflugbeil C: [Radiation risks from diagnostic radiology: meningiomas and other late effects after exposure of the skull]. Gesundheitswesen; 2010 Apr;72(4):246-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Risk estimates are derived for paediatric head CTs as well as for brain tumours in adults.
  • Dose-effect relationships for tumours of the brain, skin, thyroid, and other sites of the head region, leukaemia, and cataracts are taken from the literature.
  • The radiation-induced occurrence of meningiomas and other brain tumours most probably contributes to the continuously increasing incidence of these diseases which is observed in several industrial nations, as well as the exposure of the bone marrow by CT to the increase of childhood leukaemia.
  • [MeSH-major] Brain Neoplasms / etiology. Brain Neoplasms / radiography. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology. Skull / radiation effects. Tomography, X-Ray Computed / adverse effects
  • [MeSH-minor] Adolescent. Adult. Age Factors. Cataract / epidemiology. Cataract / etiology. Child. Child, Preschool. Cross-Sectional Studies. Dose-Response Relationship, Radiation. Follow-Up Studies. Germany. Humans. Infant. Leukemia, Radiation-Induced / epidemiology. Leukemia, Radiation-Induced / etiology. Probability. Radiation Injuries / epidemiology. Radiation Injuries / etiology. Radiation Tolerance

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Georg Thieme Verlag KG Stuttgart, New York.
  • (PMID = 19551621.001).
  • [ISSN] 1439-4421
  • [Journal-full-title] Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany))
  • [ISO-abbreviation] Gesundheitswesen
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. Puri S, Joshi BH, Sarkar C, Mahapatra AK, Hussain E, Sinha S: Expression and structure of interleukin 4 receptors in primary meningeal tumors. Cancer; 2005 May 15;103(10):2132-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Reverse transcription-polymerase chain reaction (RT-PCR) analysis for IL-13Ralpha1, IL-4Ralpha and IL-2Rgammac was performed on total RNA extracted from 35 meningiomas and a normal human brain tissue sample.
  • RESULTS: Transcripts for the IL-4Ralpha and IL-13Ralpha1 chains were overexpressed in meningiomas compared with normal brain tissue.
  • The transcripts for IL-2Rgammac chain were not detected in any of the tumor samples or in normal brain tissue.
  • These receptors may serve as a target for cytotoxin/immunotoxin therapy in patients with meningioma who are not amenable to surgical resection or for recurrent tumors.
  • [MeSH-major] Meningeal Neoplasms / chemistry. Meningioma / chemistry. Receptors, Interleukin-4 / chemistry
  • [MeSH-minor] Adult. Age Factors. Brain Chemistry. Fluorescent Antibody Technique. Gene Expression Regulation, Neoplastic. Humans. Interleukin Receptor Common gamma Subunit. Interleukin-13 / chemistry. Interleukin-13 Receptor alpha1 Subunit. Middle Aged. RNA, Messenger / analysis. Receptors, Interleukin / chemistry. Receptors, Interleukin-13. Receptors, Interleukin-2 / chemistry. Reverse Transcriptase Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15830341.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / IL13RA1 protein, human; 0 / IL2RG protein, human; 0 / Interleukin Receptor Common gamma Subunit; 0 / Interleukin-13; 0 / Interleukin-13 Receptor alpha1 Subunit; 0 / RNA, Messenger; 0 / Receptors, Interleukin; 0 / Receptors, Interleukin-13; 0 / Receptors, Interleukin-2; 0 / Receptors, Interleukin-4
  •  go-up   go-down


16. Kashimura H, Ogasawara K, Arai H, Beppu T, Inoue T, Takahashi T, Matsuda K, Takahashi Y, Fujiwara S, Ogawa A: Fusion of magnetic resonance angiography and magnetic resonance imaging for surgical planning for meningioma--technical note. Neurol Med Chir (Tokyo); 2008 Sep;48(9):418-21; discussion 422
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fusion of magnetic resonance angiography and magnetic resonance imaging for surgical planning for meningioma--technical note.
  • A fusion technique for magnetic resonance (MR) angiography and MR imaging was developed to help assess the peritumoral angioarchitecture during surgical planning for meningioma.
  • Three-dimensional time-of-flight (3D-TOF) and 3D-spoiled gradient recalled (SPGR) datasets were obtained from 10 patients with intracranial meningioma, and fused using newly developed volume registration and visualization software.
  • Fusion of MR angiography and MR imaging can clarify relationships between the intracranial vasculature and meningioma, and may be helpful for surgical planning for meningioma.
  • [MeSH-major] Brain Neoplasms / surgery. Magnetic Resonance Angiography / methods. Magnetic Resonance Imaging / methods. Meningioma / surgery. Surgery, Computer-Assisted / methods
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Patient Care Planning. Software

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18812687.001).
  • [ISSN] 1349-8029
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  •  go-up   go-down


17. Messing-Jünger AM, Riemenschneider MJ, Reifenberger G: A 21-year-old female with a third ventricular tumor. Brain Pathol; 2006 Jan;16(1):87-8, 93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • On magnetic resonance imaging of the brain, she demonstrated a small contrast-enhancing mass in the posterior part of the third ventricle.
  • Histologically, intraventricular schwannoma needs to be distinguished from other spindle cell tumors, in particular pilocytic astrocytoma and fibroblastic meningioma.
  • [MeSH-minor] Adult. Brain / pathology. Female. Humans. Magnetic Resonance Imaging. Neurosurgical Procedures

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16612987.001).
  • [ISSN] 1015-6305
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Switzerland
  •  go-up   go-down


18. Chamberlain MC, Tsao-Wei DD, Groshen S: Salvage chemotherapy with CPT-11 for recurrent meningioma. J Neurooncol; 2006 Jul;78(3):271-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salvage chemotherapy with CPT-11 for recurrent meningioma.
  • BACKGROUND: A prospective Phase II study of irinotecan (CPT-11) in adult patients with recurrent surgery and radiotherapy-refractory WHO Grade I meningioma.
  • METHODS: Sixteen patients (5 men; 11 women) ages 48-70 years (median 62.5), with recurrent meningioma were treated.
  • Using CPT-11 in this moderately toxic dose schedule failed to demonstrate efficacy in this cohort of adult patients with recurrent surgery and radiotherapy-refractory meningioma.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / administration & dosage. Brain Neoplasms / drug therapy. Camptothecin / analogs & derivatives. Meningioma / drug therapy. Neoplasm Recurrence, Local / drug therapy. Salvage Therapy

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 1994 Nov;81(5):666-75 [7931612.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):271-5 [9007858.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):486-90 [1619417.001]
  • [Cites] J Neurooncol. 1990 Feb;8(1):61-5 [2319292.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):801-6 [12788188.001]
  • [Cites] J Neurosurg. 1999 Jan;90(1):42-9 [10413154.001]
  • [Cites] J Neurosurg. 1991 Jun;74(6):861-6 [2033444.001]
  • [Cites] J Clin Oncol. 1990 Jul;8(7):1277-80 [2358840.001]
  • [Cites] J Neurosurg. 1997 May;86(5):845-52 [9126901.001]
  • [Cites] J Neurooncol. 1996 Sep;29(3):197-205 [8858525.001]
  • [Cites] J Neurooncol. 2000 Sep;49(2):165-70 [11206012.001]
  • [Cites] J Neurosurg. 1994 Feb;80(2):195-201 [8283256.001]
  • [Cites] J Neurooncol. 1996 Sep;29(3):269-72 [8858533.001]
  • [Cites] J Neurosurg. 1996 May;84(5):733-6 [8622144.001]
  • [Cites] J Clin Oncol. 2002 Mar 1;20(5):1375-82 [11870182.001]
  • [Cites] J Neurosurg. 2002 Aug;97(2):341-6 [12186462.001]
  • [Cites] J Neurosurg. 1990 Oct;73(4):545-7 [2398385.001]
  • [Cites] J Neurosurg. 2002 Jul;97(1):65-72 [12134934.001]
  • [Cites] Neurology. 1997 May;48(5):1459-62 [9153494.001]
  • [Cites] Neurology. 1998 Dec;51(6):1718-20 [9855530.001]
  • [Cites] J Neurosurg. 1985 Jan;62(1):18-24 [3964853.001]
  • [Cites] Lancet. 1995 Feb 4;345(8945):331 [7837901.001]
  • [Cites] Surg Neurol. 1986 Nov;26(5):461-9 [3764651.001]
  • [Cites] J Neurosurg. 1994 Feb;80(2):187-90 [8283254.001]
  • [Cites] J Neurosurg. 1991 Apr;74(4):552-9 [2002367.001]
  • (PMID = 16628476.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticonvulsants; 0 / Antineoplastic Agents, Phytogenic; 0H43101T0J / irinotecan; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


19. Kozler P, Benes V, Netuka D, Kramár F, Charvát F: Intracranial meningioma surgery outcome--the impact of preoperative neuroimaging. Prague Med Rep; 2006;107(3):327-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial meningioma surgery outcome--the impact of preoperative neuroimaging.
  • The present study is aimed at finding radiological parameters which could provide indirect information on invasive growth of meningioma, relevant enough to predict the possible risk of postoperative neurological deficit development.
  • The cohort was composed of 40 consecutive adult patients of comparable general condition parameters (age 18-75 years, KRS 70-100, ASA 1-2) with meningiomas attacking with the whole of their volume solely the brain tissue.
  • As follows from the outcome, meningioma growth in the eloquent area and the presence of peritumoral oedema are the two adverse parameters predicting the development of postoperative neurological deficit.
  • In contrast, dural type of vascularisation, visible tumour-brain interface, meningioma growing in a non-eloquent area and the absence of peritumoral oedema are favourable predictive parameters.
  • [MeSH-major] Magnetic Resonance Imaging. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17385405.001).
  • [ISSN] 1214-6994
  • [Journal-full-title] Prague medical report
  • [ISO-abbreviation] Prague Med Rep
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Czech Republic
  •  go-up   go-down


20. Pereira-Filho Nde A, Soares FP, Chemale Ide M, Coutinho LM: Peritumoral brain edema in intracranial meningiomas. Arq Neuropsiquiatr; 2010 Jun;68(3):346-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritumoral brain edema in intracranial meningiomas.
  • Occurrence of peritumoral brain edema (PBE) in meningiomas has been associated with several factors in recent years, although its pathophysiological mechanism has not yet been fully elucidated.
  • [MeSH-major] Brain Edema / pathology. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Retrospective Studies. Severity of Illness Index. Sex Factors. Tumor Burden. Young Adult

  • Genetic Alliance. consumer health - Edema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20602033.001).
  • [ISSN] 1678-4227
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


21. Drevelegas A, Xinou E, Karacostas D, Parissis D, Karkavelas G, Milonas I: Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship? Neuroradiology; 2005 Jul;47(7):516-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship?
  • Although the coincidence of multiple sclerosis (MS) and central nervous system (CNS) tumors has been reported in over 30 cases in English literature, meningioma growth was associated with interferon-beta (INF-b) treated MS only in two of them.
  • We report the case of a 19-year-old woman with clinically possible, laboratory supported MS, and a concomitant right intraventricular tumor with magnetic resonance imaging (MRI) characteristics consistent with meningioma (similar signal with grey matter on T1 and T2-weighted images and homogenous, intense enhancement).
  • Two years after initiation of INF-b treatment, follow-up brain MRI revealed enlargement of the intraventricular mass and relative increase in the number of white matter lesions without significant clinical deterioration.
  • She underwent almost total resection of the mass and histology confirmed the diagnosis of papillary meningioma.
  • Based on the immunohistochemistry results, we speculate that INF-b resulted in meningioma growth by enhancing platelet derived growth factor (PDGF) receptors or/and down-regulating transforming growth factor receptors on the tumor itself.
  • [MeSH-major] Adjuvants, Immunologic / adverse effects. Cerebral Ventricle Neoplasms / diagnosis. Interferon-beta / adverse effects. Magnetic Resonance Imaging. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Multiple Sclerosis / drug therapy
  • [MeSH-minor] Adult. Female. Humans. Immunohistochemistry. Interferon beta-1b. Receptors, Platelet-Derived Growth Factor / metabolism

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - Multiple Sclerosis.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Multiple Sclerosis.
  • Hazardous Substances Data Bank. Interferon Beta-1b .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anticancer Res. 1996 Mar-Apr;16(2):717-23 [8687119.001]
  • [Cites] N Engl J Med. 1997 Apr 17;336(16):1163-71 [9099662.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):271-5 [9007858.001]
  • [Cites] Neurology. 2002 Sep 24;59(6):802-8 [12349849.001]
  • [Cites] Acta Neurol Scand. 1991 Sep;84(3):214-20 [1950464.001]
  • [Cites] Arq Neuropsiquiatr. 2000 Dec;58(4):1133-7 [11105086.001]
  • [Cites] J Exp Med. 1994 Nov 1;180(5):1961-6 [7525845.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):216-8 [1564485.001]
  • [Cites] Surg Neurol. 1986 Jul;26(1):45-51 [3715699.001]
  • [Cites] Ann Neurol. 2001 Jun;49(6):776-85 [11409430.001]
  • [Cites] Eur Neurol. 1980;19(3):192-7 [7389764.001]
  • [Cites] Semin Cancer Biol. 1992 Apr;3(2):89-96 [1378314.001]
  • [Cites] J Neurol. 1978 Apr 14;218(1):23-33 [77315.001]
  • [Cites] J Neurosurg. 2001 Feb;94(2):293-300 [11213968.001]
  • [Cites] Neurology. 1997 May;48(5):1330-3 [9153467.001]
  • [Cites] J Neurosurg. 1999 Sep;91(3):440-6 [10470819.001]
  • [Cites] Acta Neurochir (Wien). 2002 Apr;144(4):365-8 [12021883.001]
  • (PMID = 15981002.001).
  • [ISSN] 0028-3940
  • [Journal-full-title] Neuroradiology
  • [ISO-abbreviation] Neuroradiology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 145155-23-3 / Interferon beta-1b; 77238-31-4 / Interferon-beta; EC 2.7.10.1 / Receptors, Platelet-Derived Growth Factor
  •  go-up   go-down


22. Einav S, Shoshan Y, Ovadia H, Matot I, Hersch M, Itshayek E: Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study. Crit Care; 2006;10(5):R141
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study.
  • This study evaluated whether pre-/postoperative serum S100beta levels correlate with unfavourable clinical and radiological findings in patients undergoing elective meningioma resection.
  • METHODS: In 52 consecutive patients admitted for meningioma surgery, serum S100beta levels were determined upon admission and immediately, 24 hours, and 48 hours after surgery.
  • Tumour volume, brain edema, and bleeding volume were calculated using BrainSCAN software.
  • Significantly greater postcraniotomy S100beta levels were observed with prolonged surgery (p = 0.039), deterioration in the mini-mental state examination (p = 0.005, 0.011, and 0.036 for pre versus immediate, 24 hours, and 48 hours postsurgery, respectively), and with postoperative brain computed tomography evidence of brain injury; bleeding was associated with higher serum S100beta levels at 24 and 48 hours after surgery (p = 0.046, 95% confidence interval [CI] -0.095 to -0.001 and p = 0.034, 95% CI -0.142 to -0.006, respectively) as was the presence of midline shift (p = 0.005, 95% CI -0.136 to -0.025 and p = 0.006, 95% CI -0.186 to -0.032, respectively).
  • CONCLUSION: In patients with meningioma, serum S100beta levels perform poorly as an indicator of tumour characteristics but may suggest ongoing postcraniotomy injury.
  • Serum S100beta levels may serve as a potentially useful early marker of postcraniotomy brain damage in patients undergoing elective meningioma resection.
  • [MeSH-major] Brain Damage, Chronic / blood. Meningeal Neoplasms / surgery. Meningioma / surgery. Nerve Growth Factors / blood. S100 Proteins / blood
  • [MeSH-minor] Adult. Aged. Biomarkers / blood. Female. Humans. Male. Middle Aged. Postoperative Period. Predictive Value of Tests. Prospective Studies. S100 Calcium Binding Protein beta Subunit. Time Factors

  • Genetic Alliance. consumer health - Meningioma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Resuscitation. 2001 May;49(2):183-91 [11382525.001]
  • [Cites] Neuroscience. 2006 Sep 15;141(4):1697-701 [16782283.001]
  • [Cites] Scand J Clin Lab Invest. 2001 May;61(3):217-25 [11386608.001]
  • [Cites] Circulation. 2001 Jun 5;103(22):2694-8 [11390339.001]
  • [Cites] Neuroscience. 2002;109(2):371-88 [11801372.001]
  • [Cites] Pediatr Res. 2002 Feb;51(2):215-9 [11809917.001]
  • [Cites] Acta Anaesthesiol Scand. 2002 Jan;46(1):10-6 [11903066.001]
  • [Cites] Pediatr Res. 2002 Apr;51(4):492-6 [11919335.001]
  • [Cites] Obstet Gynecol. 2002 Jun;99(6):1093-9 [12052605.001]
  • [Cites] J Neurotrauma. 2002 Nov;19(11):1405-9 [12490005.001]
  • [Cites] Br J Anaesth. 2000 Feb;84(2):242-4 [10743460.001]
  • [Cites] Ann Thorac Surg. 2000 Mar;69(3):847-50 [10750771.001]
  • [Cites] Shock. 2003 Mar;19(3):195-200 [12630517.001]
  • [Cites] Minim Invasive Neurosurg. 2003 Feb;46(1):33-6 [12640581.001]
  • [Cites] Neurology. 2003 Mar 25;60(6):947-51 [12654958.001]
  • [Cites] Cancer. 2003 Jun 1;97(11):2806-13 [12767094.001]
  • [Cites] Acta Neurol Scand. 2003 Sep;108(3):161-9 [12911458.001]
  • [Cites] Anaesthesia. 2004 Apr;59(4):344-9 [15023104.001]
  • [Cites] Acta Neurochir (Wien). 2004 May;146(5):449-52 [15118880.001]
  • [Cites] J Psychiatr Res. 1975 Nov;12(3):189-98 [1202204.001]
  • [Cites] J Neurochem. 1984 Nov;43(5):1336-41 [6092538.001]
  • [Cites] Am J Physiol. 1987 Mar;252(3 Pt 1):C285-9 [3826357.001]
  • [Cites] Biochim Biophys Acta. 1999 Jul 8;1450(3):191-231 [10395934.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39 [13406590.001]
  • [Cites] Clin Chem. 2005 Jan;51(1):202-7 [15550475.001]
  • [Cites] J Neurotrauma. 2005 Jun;22(6):645-55 [15941374.001]
  • [Cites] Ann Thorac Surg. 2001 May;71(5):1512-7 [11383792.001]
  • (PMID = 17020600.001).
  • [ISSN] 1466-609X
  • [Journal-full-title] Critical care (London, England)
  • [ISO-abbreviation] Crit Care
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Nerve Growth Factors; 0 / S100 Calcium Binding Protein beta Subunit; 0 / S100 Proteins; 0 / S100B protein, human
  • [Other-IDs] NLM/ PMC1751042
  •  go-up   go-down


23. Pettorini BL, Park YS, Caldarelli M, Massimi L, Tamburrini G, Di Rocco C: Radiation-induced brain tumours after central nervous system irradiation in childhood: a review. Childs Nerv Syst; 2008 Jul;24(7):793-805
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-induced brain tumours after central nervous system irradiation in childhood: a review.
  • METHODS: The pertinent literature of both paediatric and adult series has been reviewed.
  • RESULTS: One hundred forty-two paediatric second brain tumours were evaluated.
  • Among the second tumours occurring in adults, meningioma is the most common.
  • CONCLUSION: Paediatric radiation-induced brain tumours differ from the adult counterpart for both the histological subtypes.
  • These figures indicate a specific vulnerability of the infantile brain demonstrated by the most frequent occurrence of highly malignant lesions.
  • [MeSH-major] Brain Neoplasms / etiology. Central Nervous System / radiation effects. Neoplasms, Radiation-Induced / etiology. Pediatrics
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Magnetic Resonance Imaging. Male

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Children's Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Childs Nerv Syst. 2004 Jan;20(1):46-9 [14714135.001]
  • [Cites] J Neurosurg. 1994 Nov;81(5):666-75 [7931612.001]
  • [Cites] J Neurosurg. 1987 Dec;67(6):915-8 [2824720.001]
  • [Cites] Childs Nerv Syst. 1989 Jun;5(3):135-9 [2758424.001]
  • [Cites] Neurocirugia (Astur). 2005 Jun;16(3):266-70; discussion 270 [16007326.001]
  • [Cites] J Neurosurg. 1989 Mar;70(3):469-74 [2536806.001]
  • [Cites] J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S256-9 [16227103.001]
  • [Cites] Pediatr Radiol. 2001 Sep;31(9):607-9 [11511997.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Feb;90(2):800-4 [15562021.001]
  • [Cites] Lancet. 1999 Jul 3;354(9172):34-9 [10406363.001]
  • [Cites] Neurosurg Rev. 2005 Apr;28(2):104-14 [15565500.001]
  • [Cites] J Radiat Res. 1999 Mar;40(1):49-57 [10408177.001]
  • [Cites] Br Med J (Clin Res Ed). 1984 Oct 20;289(6451):1038-9 [6435760.001]
  • [Cites] Childs Nerv Syst. 2000 Jul;16(7):390-7 [10958546.001]
  • [Cites] J Neurosurg. 1995 Mar;82(3):487-8 [7861229.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):618-29 [11309438.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):65-73 [10924973.001]
  • [Cites] Childs Nerv Syst. 2004 Apr;20(4):243-6 [14704813.001]
  • [Cites] Cancer. 1993 Oct 1;72(7):2227-33 [8374881.001]
  • [Cites] Acta Neurochir (Wien). 1997;139(8):749-55 [9309290.001]
  • [Cites] Surg Neurol. 1997 May;47(5):435-41; discussion 441-2 [9131025.001]
  • [Cites] Neurosurgery. 1998 Jan;42(1):172-8 [9442520.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1978 Nov;41(11):1005-12 [213536.001]
  • [Cites] Hematol Oncol Clin North Am. 2006 Feb;20(1):1-24 [16580554.001]
  • [Cites] Mol Cancer Ther. 2007 Mar;6(3):789-801 [17363476.001]
  • [Cites] Cancer. 1986 Aug 15;58(4):886-94 [2424587.001]
  • [Cites] J Neurosurg. 1983 Dec;59(6):1048-53 [6631499.001]
  • [Cites] Neuroradiology. 1998 Jul;40(7):435-8 [9730342.001]
  • [Cites] Br J Radiol. 1985 May;58(689):480-2 [4063702.001]
  • [Cites] J Neurosurg. 1984 Nov;61(5):966-71 [6593438.001]
  • [Cites] Surg Neurol. 2003 Jul;60(1):60-7; discussion 67 [12865017.001]
  • [Cites] Clin Neuropathol. 1994 Sep-Oct;13(5):281-5 [7805312.001]
  • [Cites] Cancer. 1998 Jan 1;82(1):8-34 [9428476.001]
  • [Cites] J Neurosurg. 1985 Feb;62(2):300-3 [3855445.001]
  • [Cites] Radiother Oncol. 2005 Jan;74(1):37-44 [15683667.001]
  • [Cites] Pediatr Neurosurg. 1996 Oct;25(4):214-9 [9293548.001]
  • [Cites] Neurosurgery. 1988 Jun;22(6 Pt 1):1095-7 [3419575.001]
  • [Cites] Med J Aust. 1986 Jul 21;145(2):96-7 [3461240.001]
  • [Cites] Cancer. 1981 Jun 1;47(11):2563-6 [6266634.001]
  • [Cites] Childs Nerv Syst. 1988 Oct;4(5):296-301 [3072075.001]
  • [Cites] J Neurosurg. 2004 Jun;100(6):1002-13 [15200115.001]
  • [Cites] Neurosurgery. 1991 Oct;29(4):606-8 [1658678.001]
  • [Cites] J Neurosurg. 1978 Apr;48(4):622-7 [632887.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):393-6 [9007876.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):1072-6 [12569608.001]
  • [Cites] Childs Nerv Syst. 2006 Sep;22(9):1201-7 [16570196.001]
  • [Cites] Cancer. 1993 Jun 15;71(12):4091-5 [8508374.001]
  • [Cites] Cancer. 2004 Jan 1;100(1):212-3 [14692043.001]
  • [Cites] J Neurosurg. 1997 Feb;86(2):286-8 [9010431.001]
  • [Cites] Neurol India. 1999 Jun;47(2):142-4 [10402343.001]
  • [Cites] J Cancer Res Ther. 2007 Jan-Mar;3(1):50-2 [17998722.001]
  • [Cites] Cancer Causes Control. 1997 Nov;8(6):865-71 [9427429.001]
  • [Cites] Neurosurgery. 1985 Sep;17(3):436-45 [2995867.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):210-21 [16472938.001]
  • [Cites] J Clin Oncol. 1993 Feb;11(2):262-70 [8426203.001]
  • [Cites] Br J Ophthalmol. 1953 Dec;37(12):758-62 [13115610.001]
  • [Cites] Neurosurgery. 1987 Jul;21(1):33-8 [3614601.001]
  • [Cites] Acta Neurochir (Wien). 2001;143(7):697-700 [11534690.001]
  • [Cites] J Neurosurg. 2004 May;100(5 Suppl Pediatrics):488-91 [15287460.001]
  • [Cites] J Clin Oncol. 2005 Aug 20;23(24):5560-7 [16110017.001]
  • [Cites] Acta Neurochir (Wien). 1998;140(8):763-70 [9810442.001]
  • [Cites] J Neurosurg. 1991 Oct;75(4):564-74 [1885974.001]
  • [Cites] Clin Oncol (R Coll Radiol). 1994;6(6):361-3 [7873481.001]
  • [Cites] Childs Nerv Syst. 1995 Nov;11(11):661-3 [8608584.001]
  • [Cites] J Pediatr Hematol Oncol. 2006 Jun;28(6):374-8 [16794506.001]
  • [Cites] Br J Neurosurg. 1995;9(5):629-37 [8561935.001]
  • [Cites] Childs Nerv Syst. 2000 May;16(5):304-8 [10883374.001]
  • [Cites] Childs Nerv Syst. 2007 Feb;23(2):185-93 [17021727.001]
  • [Cites] Blood. 2000 May 1;95(9):2770-5 [10779419.001]
  • [Cites] Neurology. 1981 May;31(5):616-9 [7194977.001]
  • [Cites] Neurosurgery. 1980 May;6(5):546-51 [6251397.001]
  • [Cites] Acta Neurochir (Wien). 1991;109(3-4):145-9 [1858533.001]
  • [Cites] Surg Neurol. 1976 Apr;5(4):215-9 [817405.001]
  • [Cites] Surg Neurol. 1974 May;2(3):161-4 [4829030.001]
  • [Cites] Dtsch Med Wochenschr. 1979 Jul 6;104(27):969-72 [456271.001]
  • [Cites] J Neurosurg. 1995 Jul;83(1):154-62 [7782835.001]
  • [Cites] Clin Neurol Neurosurg. 1998 Mar;100(1):56-9 [9637208.001]
  • [Cites] Neurochirurgia (Stuttg). 1972 Jul;15(4):135-43 [5069877.001]
  • [Cites] Cancer. 1959 Jul-Aug;12(4):791-8 [13663024.001]
  • [Cites] Pediatr Neurosci. 1988;14(6):319-23 [3270054.001]
  • [Cites] Childs Nerv Syst. 2008 Jan;24(1):71-8 [17906866.001]
  • [Cites] J Nucl Med. 1996 Jul;37(7):1174-6 [8965192.001]
  • [Cites] Neurosurgery. 2003 Jun;52(6):1436-40; discussion 1440-2 [12762888.001]
  • [Cites] J Neurosurg. 1981 Aug;55(2):282-6 [7252552.001]
  • [Cites] Onkologie. 2001 Feb;24(1):66-72 [11441284.001]
  • [Cites] Neurosurgery. 1988 Apr;22(4):758-61 [3163779.001]
  • [Cites] J Neurosurg. 2005 May;102(4 Suppl):417-22 [15926395.001]
  • [Cites] Cancer. 2004 May 15;100(10):2246-52 [15139071.001]
  • [Cites] Aust N Z J Surg. 1987 Feb;57(2):133-5 [3475054.001]
  • [Cites] J Neurosurg. 1993 Jul;79(1):28-31 [8315464.001]
  • [Cites] Can J Neurol Sci. 1992 Nov;19(4):498-503 [1330262.001]
  • [Cites] J Neurosurg. 1978 Sep;49(3):445-9 [682008.001]
  • (PMID = 18392837.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Germany
  • [Number-of-references] 93
  •  go-up   go-down


24. Xiao HL, Eyden B, Yan XC, Wang Y, Zhang R, Bian XW: Intraparenchymal myofibromatosis of the brain in an adult: report of an unusual case. Neuropathology; 2010 Jun;30(3):288-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraparenchymal myofibromatosis of the brain in an adult: report of an unusual case.
  • An unusual case of intraparenchymal myofibromatosis of the brain occurring in a 29-year-old woman is described.
  • Intraparenchymal myofibromatosis may be confused with, and should be distinguished from, meningioma, myopericytoma, solitary fibrous tumor, leiomyoma and inflammatory myofibroblastic tumor for accurate diagnosis and optimal treatment.
  • [MeSH-major] Brain Neoplasms / diagnosis. Myofibromatosis / diagnosis
  • [MeSH-minor] Adult. Female. Humans

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19845864.001).
  • [ISSN] 1440-1789
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Australia
  •  go-up   go-down


25. Paiva Neto MA, Tella OI Jr, Herculano MA, Stávale JN, Bonatteli AP: [Olfactory groove meningioma: correlation between clinicoradiological features and proliferative index (Mib-1)]. Arq Neuropsiquiatr; 2006 Mar;64(1):77-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Olfactory groove meningioma: correlation between clinicoradiological features and proliferative index (Mib-1)].
  • METHOD: There were analysed demographic, clinical and radiological features of 15 patients with olfactory groove meningioma.
  • [MeSH-major] Ki-67 Antigen / metabolism. Meningeal Neoplasms / pathology. Meningioma / pathology. Meningioma / radiography. Neoplasm Proteins / metabolism. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Adult. Aged. Antibodies, Monoclonal / analysis. Brain Edema / pathology. Brain Edema / radiography. Cell Division / physiology. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Retrospective Studies. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16622558.001).
  • [ISSN] 0004-282X
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] por
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Ki-67 Antigen; 0 / Neoplasm Proteins
  •  go-up   go-down


26. Lachenal F, Cotton F, Desmurs-Clavel H, Haroche J, Taillia H, Magy N, Hamidou M, Salvatierra J, Piette JC, Vital-Durand D, Rousset H: Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol; 2006 Oct;253(10):1267-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report 6 cases of ECD with neurological involvement and neuroradiological abnormalities on brain MRI.
  • Neuroradiological findings could be separated into three patterns: the infiltrative pattern (44%), with widespread lesions, nodules or intracerebral masses, the meningeal pattern (37%), with either thickening of the dura mater or meningioma-like tumors, and the composite pattern (19%), with both infiltrative and meningeal lesions.
  • [MeSH-minor] Adult. Disease Progression. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Radiography. Seizures / etiology

  • Genetic Alliance. consumer health - Erdheim-Chester Disease (ECD).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Med Pediatr Oncol. 2003 Dec;41(6):575-7 [14595723.001]
  • [Cites] Neuroradiology. 2002 Dec;44(12):1004-7 [12483447.001]
  • [Cites] Hum Pathol. 1999 Sep;30(9):1093-6 [10492045.001]
  • [Cites] Clin Neuropathol. 2003 Sep-Oct;22(5):246-51 [14531550.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1999 Jan;66(1):72-5 [9886456.001]
  • [Cites] Clin Orthop Relat Res. 1984 May;(185):241-4 [6705387.001]
  • [Cites] Medicine (Baltimore). 2004 Nov;83(6):371-92 [15525849.001]
  • [Cites] Mov Disord. 1998 May;13(3):576-81 [9613758.001]
  • [Cites] Arch Neurol. 1969 Aug;21(2):115-20 [4978861.001]
  • [Cites] J Neurosurg. 2004 Jun;100(6):1115-8 [15200134.001]
  • [Cites] Clin Nucl Med. 1982 Oct;7(10 ):468 [7140108.001]
  • [Cites] Nervenarzt. 2001 Jun;72(6):449-52 [11433705.001]
  • [Cites] J Neurooncol. 2002 Sep;59(2):169-72 [12241111.001]
  • [Cites] AJNR Am J Neuroradiol. 1995 Oct;16(9):1787-90 [8693976.001]
  • [Cites] Radiologe. 1991 Jun;31(6):307-9 [1882073.001]
  • [Cites] Ann Neurol. 1993 May;33(5):549-54 [8498832.001]
  • [Cites] J Cutan Med Surg. 2003 Mar-Apr;7(2):129-32 [12447617.001]
  • [Cites] Neurosurgery. 1990 Nov;27(5):822-6 [2175401.001]
  • [Cites] Rev Neurol (Paris). 2004 May;160(5 Pt 1):585-8 [15269681.001]
  • [Cites] Eur J Intern Med. 2003 Feb;14(1):53-55 [12554012.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):675-8 [11032628.001]
  • [Cites] Radiology. 2005 Jan;234(1):111-5 [15618378.001]
  • [Cites] J Rheumatol. 2000 Jun;27(6):1550-3 [10852289.001]
  • [Cites] J Intern Med. 1998 Dec;244(6):529-35 [9893107.001]
  • [Cites] J Urol. 2003 Apr;169(4):1470-1 [12629387.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Oct;86(10):4603-10 [11600510.001]
  • [Cites] Arch Pathol Lab Med. 2003 Aug;127(8):e337-9 [12873197.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 2002 Aug;110(5):248-52 [12148090.001]
  • [Cites] Ann Pathol. 1995;15(1):59-62 [7702670.001]
  • [Cites] Neuroradiology. 2003 Apr;45(4):241-5 [12687308.001]
  • [Cites] J Neurosurg. 2002 Feb;96(2):344-51 [11838810.001]
  • [Cites] Radiology. 1989 Sep;172(3):791-2 [2772189.001]
  • [Cites] J Neuropathol Exp Neurol. 1997 Nov;56(11):1207-16 [9370231.001]
  • [Cites] Adv Anat Pathol. 2003 May;10(3):160-71 [12717118.001]
  • [Cites] J Fr Ophtalmol. 1995;18(3):220-5 [7759761.001]
  • [Cites] Clin Rheumatol. 2003 Dec;22(6):464-6 [14677030.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 Jan;25(1):134-7 [14729543.001]
  • [Cites] Clin Neuropathol. 2002 Jan-Feb;21(1):24-8 [11846041.001]
  • [Cites] J Radiol. 1996 Dec;77(12 ):1213-21 [9033881.001]
  • [Cites] J Comput Assist Tomogr. 2002 Mar-Apr;26(2):257-61 [11884783.001]
  • [Cites] Ann Dermatol Venereol. 1998 May;125(5):335-8 [9747283.001]
  • [Cites] Mol Imaging Biol. 2004 Jan-Feb;6(1):63-7 [15018830.001]
  • [Cites] J Bone Joint Surg Am. 1989 Mar;71(3):456-64 [2925725.001]
  • [Cites] Am J Surg Pathol. 1999 Jan;23 (1):17-26 [9888700.001]
  • [Cites] Neurology. 1997 Dec;49(6):1702-5 [9409372.001]
  • [Cites] Eur J Nucl Med. 1990;16(1):55-60 [2407535.001]
  • [Cites] AJNR Am J Neuroradiol. 1995 Apr;16(4):735-40 [7611030.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):238-40 [7876861.001]
  • [Cites] J Neurosurg. 1997 May;86(5):888-92 [9126908.001]
  • [Cites] Clin Nucl Med. 1999 Apr;24(4):252-5 [10466521.001]
  • [Cites] Eur Neurol. 2000;43(4):242-4 [10828658.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):597-9 [9771797.001]
  • [Cites] Am J Surg Pathol. 1994 Aug;18(8):843-8 [8037299.001]
  • [Cites] Arch Pathol Lab Med. 2004 Jun;128(6):682-5 [15163229.001]
  • [Cites] Endocr Pathol. 2002 Winter;13(4):361-8 [12665654.001]
  • [Cites] Headache. 2004 Oct;44(9):911-5 [15447701.001]
  • [Cites] Clin Exp Pathol. 1999;47(2):71-6 [10398577.001]
  • (PMID = 17063320.001).
  • [ISSN] 0340-5354
  • [Journal-full-title] Journal of neurology
  • [ISO-abbreviation] J. Neurol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 58
  •  go-up   go-down


27. Vranic A, Popovic M, Cör A, Prestor B, Pizem J: Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery; 2010 Oct;67(4):1124-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients.
  • OBJECTIVE: To evaluate the prognostic significance of various histological and clinical parameters in AMMs, with an emphasis on location, mitotic count, brain invasion, and Ki67 labeling index.
  • RESULTS: High mitotic count, brain invasion, and the parasagittal-falcine location of the tumor were significantly associated with decreased recurrence-free survival in multivariate analysis.
  • Brain invasion was present in 25 of 37 cases in which brain tissue was identified in the tumor specimens.
  • When brain invasion was not included in the analysis because of the limited number of cases in which it could be assessed, high mitotic count, Ki67 index >4%, the presence of macronucleoli, and parasagittal-falcine location were significant predictors of shorter recurrence-free survival.
  • Recurrence-free survival can be further stratified by location and histological parameters, especially mitotic count, brain invasion, and Ki67 labeling index.
  • Not only brain invasion, but also the presence or absence of brain tissue in surgical specimens should be reported, because the absence of brain invasion, when brain tissue is identified, provides very important positive prognostic information.
  • [MeSH-major] Brain / pathology. Meningeal Neoplasms. Meningioma. Mitotic Index. Neoplasm Recurrence, Local / mortality
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Ki-67 Antigen / metabolism. Male. Middle Aged. Prognosis. Retrospective Studies. Survival Analysis. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20881577.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen
  •  go-up   go-down


28. Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD: New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst; 2006 Nov 1;98(21):1528-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Subsequent primary neoplasms of the central nervous system (CNS) have frequently been described as late events following childhood leukemia and brain tumors.
  • Radiation exposure was associated with increased risk of subsequent glioma (OR = 6.78, 95% CI = 1.54 to 29.7) and meningioma (OR = 9.94, 95% CI = 2.17 to 45.6).
  • The dose response for the excess relative risk was linear (for glioma, slope = 0.33 [95% CI = 0.07 to 1.71] per Gy, and for meningioma, slope = 1.06 [95% CI = 0.21 to 8.15] per Gy).
  • The higher risk of subsequent glioma in children irradiated at a very young age may reflect greater susceptibility of the developing brain to radiation.
  • [MeSH-major] Brain / drug effects. Brain Neoplasms / epidemiology. Neoplasms, Second Primary / epidemiology. Survivors / statistics & numerical data
  • [MeSH-minor] Adolescent. Adult. Age Factors. Canada / epidemiology. Case-Control Studies. Central Nervous System Neoplasms / epidemiology. Child. Child, Preschool. Dose-Response Relationship, Radiation. Female. Glioma / epidemiology. Humans. Incidence. Logistic Models. Male. Meningioma / epidemiology. Neoplasms / therapy. Odds Ratio. Radiometry. Radiotherapy / adverse effects. Retrospective Studies. Risk Assessment. Risk Factors. United States / epidemiology

  • Genetic Alliance. consumer health - Childhood Cancer.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Natl Cancer Inst. 2006 Nov 1;98(21):1510-1 [17077348.001]
  • (PMID = 17077355.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] eng
  • [Grant] United States / PHS HHS / / U24 55727; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


29. Kurokawa R, Kawase T: Spinal arachnoid cyst causing paraplegia following skull base surgery. Neurol Med Chir (Tokyo); 2006 Jun;46(6):309-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 40-year-old woman presented with a right petroclival meningioma compressing the brainstem and manifesting as a 6-month history of headache and gait difficulty.
  • Magnetic resonance (MR) imaging of the brain showed enlargement of the ventricles and no residual brainstem compression.
  • The patient's gait gradually deteriorated, although repeat brain MR imaging showed no significant increase in ventricular size.
  • [MeSH-major] Arachnoid Cysts / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Postoperative Complications / surgery. Spinal Cord Compression / surgery
  • [MeSH-minor] Adult. Cerebrospinal Fluid Shunts. Decompression, Surgical. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Hydrocephalus / diagnosis. Hydrocephalus / surgery. Laminectomy. Magnetic Resonance Imaging. Neoplasm, Residual / diagnosis. Neurologic Examination. Recurrence. Reoperation. Thoracic Vertebrae / pathology. Thoracic Vertebrae / surgery

  • Genetic Alliance. consumer health - Paraplegia.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16794354.001).
  • [ISSN] 0470-8105
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


30. Kubo O, Chernov M, Izawa M, Hayashi M, Muragaki Y, Maruyama T, Hori T, Takakura K: Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation? Minim Invasive Neurosurg; 2005 Dec;48(6):334-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation?
  • Three presented cases fulfilled these diagnostic criteria; however, it seems that progression of the tumors (schwannoma, meningioma, chordoma) resulted from the natural course of the disease, rather than represented side effects of gamma knife radiosurgery.
  • [MeSH-major] Brain Neoplasms / surgery. Cell Transformation, Neoplastic / radiation effects. Chordoma / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Neoplasms, Radiation-Induced / physiopathology. Neurilemmoma / surgery. Radiosurgery / adverse effects
  • [MeSH-minor] Adult. Brain Diseases / surgery. Cell Proliferation. Female. Humans. Male. Middle Aged. Prognosis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16432782.001).
  • [ISSN] 0946-7211
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


31. Govindan A, Mahadevan A, Bhat DI, Arivazhagan A, Chakraborti S, Suja MS, Phalguni AA, Sampath S, Chandramouli BA, Shankar SK: Papillary glioneuronal tumor-evidence of stem cell origin with biphenotypic differentiation. J Neurooncol; 2009 Oct;95(1):71-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Brain Neoplasms / pathology. Carcinoma, Papillary / pathology. Neoplastic Stem Cells / pathology. Neuroglia / pathology. Neurons / pathology
  • [MeSH-minor] AC133 Antigen. Adult. Antigens, CD / metabolism. Glycoproteins / metabolism. Humans. Male. Meningioma. Middle Aged. Nerve Tissue Proteins / metabolism. Peptides / metabolism

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 2005 Jul;185(1):265-7 [15972434.001]
  • [Cites] Clin Neuropathol. 2008 Sep-Oct;27(5):317-24 [18808063.001]
  • [Cites] Am J Surg Pathol. 1998 Oct;22(10 ):1171-83 [9777979.001]
  • [Cites] Brain Pathol. 2003 Jan;13(1):115-7 [12580553.001]
  • [Cites] Folia Neuropathol. 2008;46(2):158-63 [18587711.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2006 Dec;35(12):764-5 [17374269.001]
  • [Cites] Ann Clin Lab Sci. 2008 Summer;38(3):287-92 [18715860.001]
  • [Cites] Pathol Res Pract. 2006;202(2):107-12 [16413693.001]
  • [Cites] Stem Cells Dev. 2004 Dec;13(6):658-64 [15684833.001]
  • [Cites] Gen Physiol Biophys. 1999 Dec;18 Suppl 1:25-9 [10707828.001]
  • [Cites] J Neurooncol. 2006 Dec;80(3):227-33 [16826367.001]
  • [Cites] Acta Neuropathol. 2000 Mar;99(3):321-6 [10663977.001]
  • [Cites] J Neurosurg Pediatr. 2008 Jan;1(1):99-102 [18352813.001]
  • [Cites] Hum Pathol. 2006 Jul;37(7):914-8 [16784993.001]
  • [Cites] Neuropathology. 2007 Oct;27(5):468-73 [18018482.001]
  • [Cites] J Neurooncol. 2006 Nov;80(2):185-9 [16703452.001]
  • [Cites] Childs Nerv Syst. 2007 Mar;23(3):349-53 [17058084.001]
  • [Cites] Neuropathology. 2006 Jun;26(3):206-11 [16771176.001]
  • [Cites] Brain Pathol. 2007 Jul;17(3):308-13 [17598823.001]
  • [Cites] Hum Pathol. 2006 May;37(5):627-30 [16647962.001]
  • [Cites] Pol J Pathol. 2003;54(1):75-8 [12817884.001]
  • [Cites] Br J Neurosurg. 2006 Apr;20(2):90-3 [16753624.001]
  • [Cites] J Clin Neurosci. 2006 Nov;13(9):950-2 [17049863.001]
  • [Cites] Arq Neuropsiquiatr. 2004 Sep;62(3B):869-72 [15476085.001]
  • [Cites] No Shinkei Geka. 2003 Nov;31(11):1185-90 [14655590.001]
  • [Cites] Pediatr Neurosurg. 2002 May;36(5):266-70 [12053046.001]
  • [Cites] Neuropathology. 2006 Jun;26(3):243-8 [16771182.001]
  • [Cites] Acta Neuropathol. 1997 Aug;94(2):187-91 [9255395.001]
  • [Cites] Acta Neuropathol. 2005 Jul;110(1):39-47 [15906048.001]
  • [Cites] Brain Tumor Pathol. 2002;19(1):35-9 [12455887.001]
  • [Cites] Clin Neuropathol. 2002 Jan-Feb;21(1):1-4 [11846038.001]
  • [Cites] Clin Neuropathol. 2008 Mar-Apr;27(2):72-7 [18402385.001]
  • [Cites] Arch Pathol Lab Med. 2000 Dec;124(12):1820-3 [11100065.001]
  • [Cites] J Neurooncol. 2007 Jul;83(3):319-23 [17285229.001]
  • [Cites] Diagn Pathol. 2007 Feb 08;2:6 [17288594.001]
  • (PMID = 19404583.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / AC133 Antigen; 0 / Antigens, CD; 0 / Glycoproteins; 0 / Nerve Tissue Proteins; 0 / PROM1 protein, human; 0 / Peptides
  •  go-up   go-down


32. Muller PJ, Wilson BC: Photodynamic therapy of brain tumors--a work in progress. Lasers Surg Med; 2006 Jun;38(5):384-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Photodynamic therapy of brain tumors--a work in progress.
  • BACKGROUND AND OBJECTIVES: PDT has been used in the treatment of malignant brain tumors.
  • STUDY DESIGN AND METHODS: We examined the records of 112 patients with malignant gliomas, metastatic brain tumors and meningiomas treated with Photofrin-PDT at St. Michael's Hospital, Toronto.
  • [MeSH-major] Brain Neoplasms / drug therapy. Dihematoporphyrin Ether / therapeutic use. Photochemotherapy. Photosensitizing Agents / therapeutic use
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoma / drug therapy. Carcinoma / mortality. Carcinoma / secondary. Female. Glioma / drug therapy. Glioma / mortality. Humans. Male. Meningeal Neoplasms / drug therapy. Meningeal Neoplasms / mortality. Meningioma / drug therapy. Meningioma / mortality. Middle Aged

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16788926.001).
  • [ISSN] 0196-8092
  • [Journal-full-title] Lasers in surgery and medicine
  • [ISO-abbreviation] Lasers Surg Med
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA43892
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Photosensitizing Agents; 97067-70-4 / Dihematoporphyrin Ether
  •  go-up   go-down


33. Kreil W, Luggin J, Fuchs I, Weigl V, Eustacchio S, Papaefthymiou G: Long term experience of gamma knife radiosurgery for benign skull base meningiomas. J Neurol Neurosurg Psychiatry; 2005 Oct;76(10):1425-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Meningioma / surgery. Radiosurgery / instrumentation. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Microsurgery / instrumentation. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Postoperative Complications / epidemiology. Salvage Therapy / methods. Survival Rate. Time Factors

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 1994 Aug;81(2):245-51 [8027808.001]
  • [Cites] Acta Neurochir (Wien). 1992;118(1-2):27-32 [1414527.001]
  • [Cites] Brain Pathol. 1993 Jul;3(3):255-68 [8293185.001]
  • [Cites] Acta Neurochir Suppl. 2002;84:71-6 [12379007.001]
  • [Cites] Br J Neurosurg. 1996 Feb;10(1):59-68 [8672260.001]
  • [Cites] Stereotact Funct Neurosurg. 1996;66 Suppl 1:129-33 [9032853.001]
  • [Cites] Neurosurg Clin N Am. 1999 Apr;10(2):271-80 [10099092.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(6):647-52; discussion 652-3 [10949439.001]
  • [Cites] Surg Neurol. 1999 Mar;51(3):268-73 [10086490.001]
  • [Cites] Neurosurgery. 1996 Nov;39(5):915-9; discussion 919-20 [8905745.001]
  • [Cites] Surg Neurol. 1999 Apr;51(4):412-9; discussion 419-20 [10199295.001]
  • [Cites] J Neurosurg. 1996 Jan;84(1):20-8 [8613831.001]
  • [Cites] Stereotact Funct Neurosurg. 1996;66 Suppl 1:112-20 [9032851.001]
  • [Cites] J Neurosurg. 1999 May;90(5):823-7 [10223446.001]
  • [Cites] J Neurosurg. 2000 Jan;92(1 Suppl):71-80 [10616061.001]
  • [Cites] Stereotact Funct Neurosurg. 1998 Oct;70 Suppl 1:33-40 [9782233.001]
  • [Cites] J Neurosurg. 1999 Jul;91(1):44-50 [10389879.001]
  • [Cites] J Neurosurg. 1998 Jan;88(1):43-50 [9420071.001]
  • [Cites] Neurosurgery. 1993 May;32(5):699-704; discussion 704-5 [8492844.001]
  • [Cites] J Neurosurg. 1999 Jan;90(1):42-9 [10413154.001]
  • [Cites] Stereotact Funct Neurosurg. 1999;73(1-4):72-8 [10853105.001]
  • [Cites] Surg Neurol. 1997 Apr;47(4):371-9 [9122842.001]
  • [Cites] Surg Neurol. 1999 Jul;52(1):40-4; discussion 44-5 [10390171.001]
  • [Cites] Neurosurgery. 1996 Dec;39(6):1086-94; discussion 1094-5 [8938761.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(9):921-32 [10526073.001]
  • [Cites] Acta Neurochir (Wien). 2001 Nov;143(11):1141-52 [11731865.001]
  • [Cites] Neurosurgery. 1999 Jun;44(6):1194-9; discussion 1199-200 [10371618.001]
  • [Cites] Surg Neurol. 1996 Sep;46(3):272-8; discussion 278-9 [8781598.001]
  • [Cites] Neurosurgery. 1997 Nov;41(5):1019-25; discussion 1025-7 [9361055.001]
  • [Cites] Neurosurgery. 1997 Oct;41(4):767-74; discussion 774-5 [9316037.001]
  • [Cites] Neurosurgery. 1998 Mar;42(3):437-43; discussion 443-5 [9526975.001]
  • [Cites] J Neurosurg. 1994 Dec;81(6):860-8 [7965116.001]
  • [Cites] Neurosurgery. 1996 Jul;39(1):2-7; discussion 8-9 [8805134.001]
  • [Cites] J Neurosurg. 1994 Feb;80(2):195-201 [8283256.001]
  • [Cites] Stereotact Funct Neurosurg. 1999;72 Suppl 1:67-72 [10681693.001]
  • [Cites] Neurosurgery. 2000 Mar;46(3):567-74; discussion 574-5 [10719852.001]
  • [Cites] J Neurosurg. 2000 Dec;93 Suppl 3:107-12 [11143226.001]
  • [Cites] Neurosurgery. 1995 Jul;37(1):1-9; discussion 9-10 [8587667.001]
  • [Cites] J Clin Neurosci. 2001 May;8 Suppl 1:12-4 [11386818.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):755-61 [2108937.001]
  • [Cites] Neurosurgery. 1992 Nov;31(5):813-28; discussion 828 [1436406.001]
  • [Cites] Minim Invasive Neurosurg. 1997 Sep;40(3):87-90 [9359085.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):879-85 [2777680.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(5):473-80 [10392202.001]
  • [Cites] J Neurosurg. 1985 Jan;62(1):18-24 [3964853.001]
  • [Cites] J Neurosurg. 2000 Dec;93 Suppl 3:219-22 [11143252.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):101-11 [15093905.001]
  • [Cites] Surg Neurol. 2001 Jun;55(6):325-31 [11483185.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):1021-6 [2120162.001]
  • [Cites] Stereotact Funct Neurosurg. 1993;61 Suppl 1:23-9 [8115752.001]
  • [Cites] Stereotact Funct Neurosurg. 1998 Oct;70 Suppl 1:19-32 [9782232.001]
  • [Cites] J Neurosurg. 1991 Apr;74(4):552-9 [2002367.001]
  • (PMID = 16170090.001).
  • [ISSN] 0022-3050
  • [Journal-full-title] Journal of neurology, neurosurgery, and psychiatry
  • [ISO-abbreviation] J. Neurol. Neurosurg. Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 56
  • [Other-IDs] NLM/ PMC1739368
  •  go-up   go-down


34. Masaya-anon P, Lorpattanakasem J: Intracranial tumors affecting visual system: 5-year review in Prasat Neurological Institute. J Med Assoc Thai; 2008 Apr;91(4):515-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The three most common types of intracranial tumors were meningioma (45%), pituitary adenoma (32.9%), tumors of neuroepithelial tissues (6.7%) and craniopharyngioma (6.7%).Common neuro-ophthalmological symptoms were visual blur (88.6%) and proptosis (12.1%).
  • CONCLUSION: From the study, meningioma is the most common tumor that impairs the visual pathway structures followed by pituitary adenoma.
  • [MeSH-major] Academies and Institutes. Brain Neoplasms / complications. Optic Disk / pathology. Vision Disorders / etiology. Visual Fields
  • [MeSH-minor] Adult. Aged. Eye Movements. Female. Humans. Male. Middle Aged. Retrospective Studies. Risk Factors. Thailand. Time Factors

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Vision Impairment and Blindness.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18556861.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


35. Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M: Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Brain Tumor Pathol; 2009;26(2):51-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
  • Recently, anti-phosphohistone-H3 (PHH3) antibody has been reported as a mitosis-specific marker for meningioma grading.
  • In this study, we attempted PHH3 immunostaining for our meningioma cases and verified not only the sensitivity of PHH3 immunostaining but also that of its usefulness in grading meningiomas.
  • As such, PHH3 may be a sensitive and useful marker for meningioma grading as based on the MF.
  • [MeSH-major] Histones / metabolism. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Mitotic Index / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Analysis of Variance. Eosine Yellowish-(YS). Female. Hematoxylin. Humans. Immunohistochemistry. Ki-67 Antigen / metabolism. Male. Middle Aged. Mitosis. Phosphorylation. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Meningioma.
  • Hazardous Substances Data Bank. HEMATOXYLIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19856215.001).
  • [ISSN] 1861-387X
  • [Journal-full-title] Brain tumor pathology
  • [ISO-abbreviation] Brain Tumor Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Histones; 0 / Ki-67 Antigen; TDQ283MPCW / Eosine Yellowish-(YS); YKM8PY2Z55 / Hematoxylin
  •  go-up   go-down


36. Hanimoglu H, Tanriverdi T, Kacira T, Sanus GZ, Atukeren P, Aydin S, Tunali Y, Gumustas K, Kaynar MY: Relationship between DNA damage and total antioxidant capacity in patients with transitional meningioma. Clin Neurol Neurosurg; 2007 Sep;109(7):561-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relationship between DNA damage and total antioxidant capacity in patients with transitional meningioma.
  • PURPOSE: The purpose of this study was to assess oxidative DNA damage and total antioxidant capacity (TAC) in patients with transitional meningioma (TM) and to compare the results with normal brain tissues.
  • PATIENTS AND METHODS: Oxidative DNA damage and TAC were evaluated in TM extracted from 22 patients and in normal brain tissues of 15 subjects who underwent autopsy within first 4h of death.
  • RESULTS: The median level of TAC in TM (135nmol/gwet tissue) was remarkably lower than in normal brain tissue (298nmol/gwet tissue).
  • [MeSH-major] Antioxidants / metabolism. DNA Damage / physiology. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adult. Brain / pathology. Deoxyguanosine / analogs & derivatives. Deoxyguanosine / metabolism. Female. Glutathione Peroxidase / metabolism. Glutathione Reductase / metabolism. Humans. Male. Middle Aged. Reactive Oxygen Species / metabolism. Reference Values. Statistics as Topic

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Antioxidants.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17555871.001).
  • [ISSN] 0303-8467
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Reactive Oxygen Species; 88847-89-6 / 8-oxo-7-hydrodeoxyguanosine; EC 1.11.1.9 / Glutathione Peroxidase; EC 1.8.1.7 / Glutathione Reductase; G9481N71RO / Deoxyguanosine
  •  go-up   go-down


37. Einav S: Serum S100B levels after meningioma surgery: A comparison of two laboratory assays. BMC Clin Pathol; 2008 Sep 19;8:9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.
  • Included were fifty two consecutive adult patients undergoing surgery for meningioma that provided blood samples for determination of S100B concentrations.
  • CONCLUSION: Although a generally linear relationship exists between serum S100B concentrations measured by ELISA and a commercially available kit, ELISA values tended to be higher than commercial kit measurements particularly at concentrations over 0.7 microg/L, which are suggestive of brain injury.
  • International standardization of commercial kits is required before the predictive validity of S100B for brain damage can be effectively assessed in clinical practice.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Brain Res. 1998 Nov 30;813(1):211-7 [9824701.001]
  • [Cites] Ann Thorac Surg. 2001 May;71(5):1512-7 [11383792.001]
  • [Cites] Neuroscience. 2002;109(2):371-88 [11801372.001]
  • [Cites] Clin Chem. 2005 Jan;51(1):202-7 [15550475.001]
  • [Cites] Arch Neurol. 2005 Jul;62(7):1130-4 [16009772.001]
  • [Cites] Scand J Clin Lab Invest. 2001 May;61(3):217-25 [11386608.001]
  • [Cites] Ann Thorac Surg. 2004 Jul;78(1):46-52; discussion 52-3 [15223400.001]
  • [Cites] Stroke. 1998 Feb;29(2):473-7 [9472892.001]
  • [Cites] Resuscitation. 2002 Jun;53(3):251-7 [12062839.001]
  • [Cites] Clin Biochem. 2006 Apr;39(4):349-56 [16460721.001]
  • [Cites] Lancet. 1986 Feb 8;1(8476):307-10 [2868172.001]
  • [Cites] Am J Phys Med Rehabil. 2005 Mar;84(3):153-60 [15725788.001]
  • [Cites] Clin Chem. 2003 Jun;49(6 Pt 1):967-70 [12765999.001]
  • [Cites] Am J Physiol. 1987 Mar;252(3 Pt 1):C285-9 [3826357.001]
  • [Cites] Crit Care Med. 1996 Dec;24(12):2046-52 [8968275.001]
  • [Cites] J Endovasc Ther. 2006 Feb;13(1):39-46 [16445322.001]
  • [Cites] Anesthesiology. 2006 Apr;104(4):658-66 [16571959.001]
  • [Cites] J Cell Biol. 1989 Dec;109(6 Pt 1):3063-71 [2592414.001]
  • [Cites] Crit Care. 2006;10(5):R141 [17020600.001]
  • [Cites] J Neurobiol. 1992 Jun;23(4):451-66 [1634890.001]
  • [Cites] Int J Technol Assess Health Care. 1999 Summer;15(3):573-84 [10874383.001]
  • [Cites] Pediatr Res. 2002 Apr;51(4):492-6 [11919335.001]
  • [Cites] J Neurochem. 1984 Nov;43(5):1336-41 [6092538.001]
  • [Cites] Shock. 2003 Mar;19(3):195-200 [12630517.001]
  • [Cites] J Biol Chem. 1992 May 15;267(14):9689-94 [1315768.001]
  • [Cites] Circulation. 2001 Jun 5;103(22):2694-8 [11390339.001]
  • [Cites] Clin Chem. 1997 Mar;43(3):541-3 [9068602.001]
  • [Cites] Stroke. 2000 Nov;31(11):2569-77 [11062277.001]
  • [Cites] Stroke. 1998 Nov;29(11):2363-6 [9804649.001]
  • [Cites] Biochim Biophys Acta. 1999 Jul 8;1450(3):191-231 [10395934.001]
  • [Cites] Trends Biochem Sci. 1996 Apr;21(4):134-40 [8701470.001]
  • [Cites] Cancer. 2003 Jun 1;97(11):2806-13 [12767094.001]
  • [Cites] Neurology. 2003 Mar 25;60(6):947-51 [12654958.001]
  • [Cites] Brain Res Bull. 1995;37(4):417-29 [7620916.001]
  • [Cites] Clin Chem. 2004 Jan;50(1):249-51 [14709667.001]
  • [Cites] Anaesthesia. 2004 Apr;59(4):344-9 [15023104.001]
  • [Cites] Clin Chem. 1998 May;44(5):1056-8 [9590385.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Oct;82(20):7136-9 [3863143.001]
  • [Cites] Clin Chim Acta. 2004 Apr;342(1-2):1-12 [15026262.001]
  • [Cites] Clin Chem. 2002 Jun;48(6 Pt 1):950-2 [12029017.001]
  • [Cites] Crit Care Med. 2005 Sep;33(9):2074-81 [16148483.001]
  • [Cites] J Neurotrauma. 2002 Nov;19(11):1405-9 [12490005.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 May 1;88(9):3554-8 [1902567.001]
  • [Cites] Pediatr Res. 2002 Feb;51(2):215-9 [11809917.001]
  • (PMID = 18803814.001).
  • [ISSN] 1472-6890
  • [Journal-full-title] BMC clinical pathology
  • [ISO-abbreviation] BMC Clin Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2556325
  •  go-up   go-down


38. Umansky F, Shoshan Y, Rosenthal G, Fraifeld S, Spektor S: Radiation-induced meningioma. Neurosurg Focus; 2008;24(5):E7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-induced meningioma.
  • Emphasis is placed on meningiomas resulting from childhood treatment for primary brain tumor or tinea capitis, exposure to dental x-rays, and exposure to atomic explosions in Hiroshima and Nagasaki.
  • The authors review the typical presentation of patients with RIMs and discuss unique aspects of the surgical management of these tumors compared with sporadic meningioma, based on their clinical experience in treating these lesions.
  • [MeSH-major] Cranial Irradiation / adverse effects. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology
  • [MeSH-minor] Adolescent. Adult. Alopecia / etiology. Brain Neoplasms / radiotherapy. Child. Cohort Studies. Dose-Response Relationship, Radiation. Female. Humans. Japan / epidemiology. Male. Neoplasm Invasiveness. Neoplasms, Second Primary / etiology. Neoplasms, Second Primary / radiotherapy. Neoplasms, Second Primary / surgery. Nuclear Warfare. Radiation Injuries / epidemiology. Radiation Injuries / etiology. Radiation Injuries / prevention & control. Radiography, Dental / adverse effects. Radiosurgery / adverse effects. Radiotherapy / trends. Tinea Capitis / radiotherapy


39. Hardell L, Carlberg M, Hansson Mild K: Pooled analysis of two case-control studies on the use of cellular and cordless telephones and the risk of benign brain tumours diagnosed during 1997-2003. Int J Oncol; 2006 Feb;28(2):509-18
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pooled analysis of two case-control studies on the use of cellular and cordless telephones and the risk of benign brain tumours diagnosed during 1997-2003.
  • The use of cellular and cordless telephones and the risk of brain tumours is of concern since the brain is a high exposure area.
  • We present the results of a pooled analysis of two case-control studies on benign brain tumours diagnosed during 1997-2003 including answers from 1,254 (88%) cases and 2,162 (89%) controls aged 20-80 years.
  • Regarding meningioma, the results were as follows: for analogue phones, OR=1.3, 95% CI=0.99-1.7; for digital phones, OR=1.1, 95% CI=0.9-1.3; and for cordless phones, OR=1.1, 95% CI=0.9-1.4.
  • [MeSH-major] Brain Neoplasms / etiology. Cell Phones. Meningioma / etiology. Neuroma, Acoustic / etiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Case-Control Studies. Female. Humans. Male. Middle Aged. Multivariate Analysis. Odds Ratio. Risk Factors. Sweden. Time Factors

  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16391807.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  •  go-up   go-down


40. Santelli L, Ramondo G, Della Puppa A, Ermani M, Scienza R, d'Avella D, Manara R: Diffusion-weighted imaging does not predict histological grading in meningiomas. Acta Neurochir (Wien); 2010 Aug;152(8):1315-9; discussion 1319
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Pre-operative DWI of 102 patients (74 females, mean age 58 years, age range 34-85 years) affected by a pathologically proven intracranial meningioma were retrospectively reviewed.
  • ADC values and normalised ADC(ratio) (ADC(meningioma)/ADC(normal appearing white matter)) of the neoplastic tissue (avoiding calcifications and cystic or necrotic areas) were measured by two neuroradiologists unaware of each others' reading.
  • ADC values or ADC(ratio) did not differ significantly among meningioma sub-types although a nearly significant difference was found between meningothelial and transitional (post hoc analysis p = 0.06).
  • DWI intensity did not reach a significant correlation with meningioma's grading (p = 0.08).
  • [MeSH-major] Diffusion Magnetic Resonance Imaging / methods. Meningeal Neoplasms / pathology. Meningioma / pathology. Neoplasm Invasiveness / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Brain / pathology. Diagnosis, Differential. Female. Humans. Male. Meninges / pathology. Middle Aged. Observer Variation. Predictive Value of Tests. Prognosis. Reproducibility of Results. Severity of Illness Index

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20428902.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Austria
  •  go-up   go-down


41. Zhu W, Mao Y, Zhou LF, Zhang R, Chen L: Combined subtemporal and retrosigmoid keyhole approach for extensive petroclival meningioma surgery: report of experience with 7 cases. Minim Invasive Neurosurg; 2007 Apr;50(2):106-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined subtemporal and retrosigmoid keyhole approach for extensive petroclival meningioma surgery: report of experience with 7 cases.
  • [MeSH-major] Cranial Fossa, Posterior / surgery. Craniotomy / methods. Infratentorial Neoplasms / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Neurosurgical Procedures / methods
  • [MeSH-minor] Adult. Brain / pathology. Brain / radiography. Brain / surgery. Cavernous Sinus / anatomy & histology. Cavernous Sinus / pathology. Cavernous Sinus / surgery. Cranial Fossa, Middle / anatomy & histology. Cranial Fossa, Middle / pathology. Cranial Fossa, Middle / surgery. Cranial Nerves / pathology. Cranial Nerves / physiopathology. Cranial Nerves / surgery. Dura Mater / anatomy & histology. Dura Mater / pathology. Dura Mater / surgery. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Occipital Bone / anatomy & histology. Occipital Bone / pathology. Occipital Bone / surgery. Postoperative Complications / etiology. Postoperative Complications / prevention & control. Treatment Outcome

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17674298.001).
  • [ISSN] 0946-7211
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


42. Zele T, Matos B, Knific J, Bajrović FF, Prestor B: Use of 3D visualisation of medical images for planning and intraoperative localisation of superficial brain tumours: our experience. Br J Neurosurg; 2010 Oct;24(5):555-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of 3D visualisation of medical images for planning and intraoperative localisation of superficial brain tumours: our experience.
  • BACKGROUND: In the present article, we assessed the role, adequacy and application accuracy of intraoperative visual guidance based on the computer 3D visualisation of preoperative medical images in the surgery of superficial brain tumours.
  • MATERIALS AND METHODS: For 30 consecutive patients with convexity meningioma or cortical/subcortical brain tumour, we used 3D visualisation of post-contrast fast spoiled gradient recalled (FSPGR) MR images to plan optimal positions for the trepanation opening and/or corticotomy site.
  • CONCLUSIONS: Intraoperative visual guidance based on 3D visualisation proved to be adequate and accurate for locating superficial brain tumours in cases where transfer of planned surgical targets to the surgical field was possible.
  • [MeSH-major] Brain Neoplasms / radiography. Image Processing, Computer-Assisted. Imaging, Three-Dimensional / methods. Meningeal Neoplasms / radiography. Neuronavigation / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Monitoring, Intraoperative / methods. Preoperative Care. Surgery, Computer-Assisted. Tomography, X-Ray Computed. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20868243.001).
  • [ISSN] 1360-046X
  • [Journal-full-title] British journal of neurosurgery
  • [ISO-abbreviation] Br J Neurosurg
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


43. Gallina P, Buccoliero AM, Mariotti F, Mennonna P, Di Lorenzo N: Oncocytic meningiomas: Cases with benign histopathological features and a favorable clinical course. J Neurosurg; 2006 Nov;105(5):736-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECT: Oncocytic meningioma has recently been recognized as a distinct morphological variant of intracranial meningothelial neoplasms, and only a few cases have been reported in the literature.
  • The first description of this lesion, which was based on data in six cases, revealed a potentially aggressive nature with a tendency to infiltrate the brain and to recur.
  • Mitosis was also absent or exceedingly rare, and no brain cortex infiltration was observed.
  • CONCLUSIONS: Data in the presented cases did not confirm a previously described propensity to aggressiveness in this meningioma subtype.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningeal Neoplasms / surgery. Meningioma / pathology. Meningioma / surgery. Oxyphil Cells / physiology
  • [MeSH-minor] Adult. Antibodies, Antinuclear / metabolism. Antibodies, Monoclonal / metabolism. Female. Follow-Up Studies. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17121136.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Antinuclear; 0 / Antibodies, Monoclonal; 0 / MIB-1 antibody
  •  go-up   go-down


44. Dutta D, Lee HN, Munshi A, Gupta T, Kane S, Sridhar E, Jalali R: Intracerebral cystic rhabdoid meningioma. J Clin Neurosci; 2009 Aug;16(8):1073-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracerebral cystic rhabdoid meningioma.
  • An MRI of the brain revealed a left temporal intracerebral cystic lesion with rim enhancement.
  • The patient was diagnosed as having an intracerebral cystic rhabdoid meningioma.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / therapy. Meningioma / diagnosis. Meningioma / therapy. Rhabdoid Tumor / diagnosis. Rhabdoid Tumor / therapy
  • [MeSH-minor] Adult. Brain / pathology. Brain / radiation effects. Brain / surgery. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19427788.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


45. Hänninen MM, Haapasalo J, Haapasalo H, Fleming RE, Britton RS, Bacon BR, Parkkila S: Expression of iron-related genes in human brain and brain tumors. BMC Neurosci; 2009;10:36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of iron-related genes in human brain and brain tumors.
  • Although the expression of genes involved in normal iron balance has been intensively studied in other tissues, little is known about their expression in the brain.
  • We investigated the mRNA levels of hepcidin (HAMP), HFE, neogenin (NEO1), transferrin receptor 1 (TFRC), transferrin receptor 2 (TFR2), and hemojuvelin (HFE2) in normal human brain, brain tumors, and astrocytoma cell lines.
  • The specimens included 5 normal brain tissue samples, 4 meningiomas, one medulloblastoma, 3 oligodendrocytic gliomas, 2 oligoastrocytic gliomas, 8 astrocytic gliomas, and 3 astrocytoma cell lines.
  • Notable findings include high expression of transferrin receptor 1 in the hippocampus and medulla oblongata compared to other brain regions, low expression of HFE in normal brain with elevated HFE expression in meningiomas, and absence of hepcidin mRNA in astrocytoma cell lines despite expression in normal brain and tumor specimens.
  • CONCLUSION: These results indicate that several iron-related genes are expressed in normal brain, and that their expression may be dysregulated in brain tumors.
  • [MeSH-major] Brain / metabolism. Brain Neoplasms / metabolism. Gene Expression Regulation, Neoplastic / physiology. Histocompatibility Antigens Class I / metabolism. Membrane Proteins / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antigens, CD / genetics. Antigens, CD / metabolism. Antimicrobial Cationic Peptides / genetics. Antimicrobial Cationic Peptides / metabolism. Astrocytoma / genetics. Astrocytoma / metabolism. Cell Line, Tumor. Female. GPI-Linked Proteins. Hepcidins. Humans. Male. Meningioma / genetics. Meningioma / metabolism. Middle Aged. Oligodendroglioma / genetics. Oligodendroglioma / metabolism. RNA, Messenger / analysis. Receptors, Transferrin / genetics. Receptors, Transferrin / metabolism. Statistics, Nonparametric. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histochem Cell Biol. 2001 Mar;115(3):195-203 [11326747.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G590-4 [16537971.001]
  • [Cites] Clin Cancer Res. 2001 Aug;7(8):2213-21 [11489794.001]
  • [Cites] J Natl Cancer Inst. 2001 Sep 5;93(17):1337-43 [11535709.001]
  • [Cites] Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 [12184808.001]
  • [Cites] J Clin Invest. 2002 Oct;110(7):1037-44 [12370282.001]
  • [Cites] Biometals. 2003 Mar;16(1):63-75 [12572665.001]
  • [Cites] Blood. 2003 Aug 1;102(3):783-8 [12663437.001]
  • [Cites] Brain Res Bull. 2003 Aug 30;61(4):365-74 [12909279.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 May;5(5):343-54 [15122348.001]
  • [Cites] Nat Rev Neurosci. 2004 Nov;5(11):863-73 [15496864.001]
  • [Cites] J Neurosurg. 1990 Jun;72(6):941-5 [2159987.001]
  • [Cites] Nat Genet. 1996 Aug;13(4):399-408 [8696333.001]
  • [Cites] J Comp Neurol. 1996 Nov 25;375(4):675-92 [8930792.001]
  • [Cites] J Neurol Sci. 2004 Dec 15;227(1):27-33 [15546588.001]
  • [Cites] Science. 2004 Dec 17;306(5704):2090-3 [15514116.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Dev Comp Immunol. 2005;29(11):939-50 [15935472.001]
  • [Cites] J Biol Chem. 2005 Oct 7;280(40):33885-94 [16103117.001]
  • [Cites] BMC Neurol. 2006;6:24 [16824219.001]
  • [Cites] J Neurosci Res. 2006 Sep;84(4):790-800 [16933319.001]
  • [Cites] J Alzheimers Dis. 2006 Nov;10(2-3):215-22 [17119289.001]
  • [Cites] J Alzheimers Dis. 2006 Nov;10(2-3):267-76 [17119292.001]
  • [Cites] J Histochem Cytochem. 2007 Jan;55(1):85-96 [16982849.001]
  • [Cites] Eur J Haematol. 2007 Jan;78(1):1-10 [17042775.001]
  • [Cites] J Clin Invest. 2007 Jul;117(7):1926-32 [17557118.001]
  • [Cites] Retina. 2007 Oct;27(8):997-1003 [18040235.001]
  • [Cites] Blood. 2008 Jan 15;111(2):924-31 [17938254.001]
  • [Cites] Biochemistry. 2008 Apr 8;47(14):4237-45 [18335997.001]
  • [Cites] Cell Metab. 2008 Apr;7(4):288-90 [18396134.001]
  • [Cites] J Biol Chem. 2008 Jun 20;283(25):17494-502 [18445598.001]
  • [Cites] Nat Rev Cancer. 2008 Dec;8(12):967-75 [18987634.001]
  • [Cites] BMC Cancer. 2005;5:154 [16324219.001]
  • [Cites] Brain Pathol. 2005 Oct;15(4):297-310 [16389942.001]
  • [Cites] J Clin Oncol. 2006 Mar 10;24(8):1253-65 [16525180.001]
  • [Cites] J Biol Chem. 2001 Mar 16;276(11):7806-10 [11113131.001]
  • (PMID = 19386095.001).
  • [ISSN] 1471-2202
  • [Journal-full-title] BMC neuroscience
  • [ISO-abbreviation] BMC Neurosci
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antimicrobial Cationic Peptides; 0 / CD71 antigen; 0 / GPI-Linked Proteins; 0 / HAMP protein, human; 0 / HFE protein, human; 0 / HFE2 protein, human; 0 / Hepcidins; 0 / Histocompatibility Antigens Class I; 0 / Membrane Proteins; 0 / RNA, Messenger; 0 / Receptors, Transferrin; 0 / TFR2 protein, human; 0 / neogenin
  • [Other-IDs] NLM/ PMC2679039
  •  go-up   go-down


46. Lok C, Viseux V, Avril MF, Richard MA, Gondry-Jouet C, Deramond H, Desfossez-Tribout C, Courtade S, Delaunay M, Piette F, Legars D, Dreno B, Saïag P, Longy M, Lorette G, Laroche L, Caux F, Cancerology Group of the French Society of Dermatology: Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine (Baltimore); 2005 Mar;84(2):129-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Brain magnetic resonance imaging in patients with Cowden syndrome.
  • Other cerebral abnormalities, especially meningioma and vascular malformations, have also been described, albeit rarely, in these patients.
  • The aim of the current study was to use cerebral magnetic resonance imaging (MRI) to evaluate LDD frequency and to investigate other brain abnormalities in CS patients recruited by dermatologists.
  • Cerebral MRI revealed LDD in 3 patients, a meningioma in 1, and numerous vascular malformations in 6 patients.
  • Our findings confirm the contribution of brain MRI to detecting asymptomatic LDD, vascular malformations, and meningiomas in patients with CS.
  • [MeSH-major] Brain / pathology. Hamartoma Syndrome, Multiple / pathology. Magnetic Resonance Imaging
  • [MeSH-minor] Adolescent. Adult. Aged. Central Nervous System Venous Angioma / complications. Central Nervous System Venous Angioma / pathology. Cerebellar Neoplasms / complications. Cerebellar Neoplasms / pathology. Child. Female. Ganglioneuroma / complications. Ganglioneuroma / pathology. Hemangioma / complications. Hemangioma / pathology. Humans. Male. Meningeal Neoplasms / complications. Meningeal Neoplasms / pathology. Meningioma / complications. Meningioma / pathology. Middle Aged. Mutation. PTEN Phosphohydrolase. Phosphoric Monoester Hydrolases / genetics. Tumor Suppressor Proteins / genetics

  • Genetic Alliance. consumer health - Cowden Syndrome.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15758842.001).
  • [ISSN] 0025-7974
  • [Journal-full-title] Medicine
  • [ISO-abbreviation] Medicine (Baltimore)
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Tumor Suppressor Proteins; EC 3.1.3.- / Phosphoric Monoester Hydrolases; EC 3.1.3.48 / PTEN protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


47. Ishii K, Zaitsu M, Yonemitsu N, Kan Y, Hamasaki Y, Matsuo M: 5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines. Clin Neuropathol; 2009 Nov-Dec;28(6):445-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We investigated 5-LO expression and examined whether the 5-LO pathway is associated with the proliferation of human brain tumors.
  • METHODS: We immunohistochemically evaluated the profile of 5-LO expression in various types of brain tumors obtained from 42 patients, and examined the proliferative effects of the 5-LO pathway in human glioma cell lines using a proliferation assay.
  • RESULTS: Immunohistochemistry of glioblastomas, astrocytomas, meningiomas, medulloblastomas, craniopharyngiomas, ependymomas, neurinomas, oligodendrogliomas, malignant lymphomas, dysembryoplastic neuroepithelial and metastatic brain tumors revealed 5-LO expression in the cytoplasm and nuclei or nuclear envelopes of tumor cells.
  • CONCLUSIONS: We confirmed the expression of 5-LO in various human brain tumors and demonstrated the partial suppression of tumor growth by inhibitors of the 5-LO-LTA4 hydrolase pathway in human glioma cell lines.
  • [MeSH-major] Arachidonate 5-Lipoxygenase / physiology. Brain Neoplasms / pathology. Cell Proliferation. Glioma / pathology. Signal Transduction / physiology
  • [MeSH-minor] Adolescent. Adult. Aged. Astrocytoma / pathology. Astrocytoma / physiopathology. Child. Child, Preschool. Dose-Response Relationship, Drug. Female. Glioblastoma / pathology. Glioblastoma / physiopathology. Humans. Leucine / analogs & derivatives. Leucine / pharmacology. Leukotriene A4 / antagonists & inhibitors. Leukotriene A4 / physiology. Lipoxygenase Inhibitors. Male. Meningioma / pathology. Meningioma / physiopathology. Middle Aged. Protease Inhibitors / pharmacology. Tumor Cells, Cultured. Young Adult

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • Hazardous Substances Data Bank. L-Leucine .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19919819.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Leukotriene A4; 0 / Lipoxygenase Inhibitors; 0 / Protease Inhibitors; EC 1.13.11.34 / Arachidonate 5-Lipoxygenase; GMW67QNF9C / Leucine; I0J33N5627 / ubenimex
  •  go-up   go-down


48. Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E, Shono T, Mizoguchi M, Nagata S, Sasaki T, Suzuki SO, Iwaki T, Kobayashi K, Mihara F, Honda H: Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol; 2008 Apr;29(4):688-93
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density.
  • BACKGROUND AND PURPOSE: We investigated the relationship between tumor blood-flow measurement based on perfusion imaging by arterial spin-labeling (ASL-PI) and histopathologic findings in brain tumors.
  • MATERIALS AND METHODS: We used ASL-PI to examine 35 patients with brain tumors, including 11 gliomas, 9 meningiomas, 9 schwannomas, 1 diffuse large B-cell lymphoma, 4 hemangioblastomas, and 1 metastatic brain tumor.
  • CONCLUSION: ASL-PI may predict histopathologic vascular densities of brain tumors and may be useful in distinguishing between high- and low-grade gliomas and in differentiating hemangioblastomas from other brain tumors.
  • [MeSH-major] Brain Neoplasms / blood supply. Magnetic Resonance Imaging
  • [MeSH-minor] Adolescent. Adult. Aged. Cell Proliferation. Cerebrovascular Circulation. Child. Child, Preschool. Female. Glioma / blood supply. Glioma / pathology. Hemangioma / blood supply. Hemangioma / pathology. Humans. Male. Meningeal Neoplasms / blood supply. Meningeal Neoplasms / pathology. Meningioma / blood supply. Meningioma / pathology. Microcirculation / pathology. Middle Aged. Neurilemmoma / blood supply. Neurilemmoma / pathology. Spin Labels


49. Fu B, Zhao J, Wang B, Yang M, Xu L, Zhuo Y: Lack of the cerebral peduncle involvement in a series of adult supratentorial AVM: a diffusion tensor imaging study. Neurosci Lett; 2010 Dec 17;486(3):132-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lack of the cerebral peduncle involvement in a series of adult supratentorial AVM: a diffusion tensor imaging study.
  • During the past 2 years, 23 cases of adult supratentorial AVM patients had DTI after admission.
  • Their FA value and fiber number was compared with those of cavernous malformation (CM) and tumor (glioma and meningioma).
  • [MeSH-minor] Adult. Brain Neoplasms / pathology. Brain Neoplasms / physiopathology. Diffusion Tensor Imaging / methods. Efferent Pathways / pathology. Efferent Pathways / physiopathology. Female. Humans. Male. Middle Aged. Nerve Fibers, Myelinated / pathology. Nerve Regeneration / physiology. Neuronal Plasticity / physiology. Pyramidal Tracts / pathology. Pyramidal Tracts / physiopathology. Young Adult

  • MedlinePlus Health Information. consumer health - Arteriovenous Malformations.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20833228.001).
  • [ISSN] 1872-7972
  • [Journal-full-title] Neuroscience letters
  • [ISO-abbreviation] Neurosci. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  •  go-up   go-down


50. Fu JY, Gao XG, Li SY, Wang LZ, Hu YJ: [Ectopic meningioma in oral and maxillofacial region: report of 23 cases]. Shanghai Kou Qiang Yi Xue; 2010 Feb;19(1):23-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ectopic meningioma in oral and maxillofacial region: report of 23 cases].
  • PURPOSE: To analyse the clinical features and treatment of ectopic meningioma (EM) in oral and maxillofacial region.
  • The CT image of EM in the oral and maxillofacial region was similar to that in the brain.
  • [MeSH-major] Meningioma. Mouth Neoplasms. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Female. Humans. Male. Meningeal Neoplasms. Retrospective Studies

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20300688.001).
  • [ISSN] 1006-7248
  • [Journal-full-title] Shanghai kou qiang yi xue = Shanghai journal of stomatology
  • [ISO-abbreviation] Shanghai Kou Qiang Yi Xue
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


51. Gabeau-Lacet D, Engler D, Gupta S, Scangas GA, Betensky RA, Barker FG 2nd, Loeffler JS, Louis DN, Mohapatra G: Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome. J Neuropathol Exp Neurol; 2009 Oct;68(10):1155-65
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Given the heterogeneous treatment outcomes of atypical meningioma, investigation of large-scale and focal genomic alterations in multi-institutional efforts may help clarify molecular-genetic signatures of clinical use.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Neurol Belg. 2002 Jun;102(2):53-62 [12161900.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):145-53 [11958368.001]
  • [Cites] Cancer Genet Cytogenet. 2003 Jan 15;140(2):99-106 [12645646.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5 [12883005.001]
  • [Cites] Oncogene. 2004 Jan 29;23(4):1014-20 [14749765.001]
  • [Cites] Surg Neurol. 2004 Feb;61(2):171-3 [14751635.001]
  • [Cites] Biostatistics. 2004 Oct;5(4):557-72 [15475419.001]
  • [Cites] Neurosurgery. 1992 Jul;31(1):2-12 [1641106.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):180-4 [8162072.001]
  • [Cites] Cancer Res. 1995 Oct 15;55(20):4696-701 [7553651.001]
  • [Cites] Genes Chromosomes Cancer. 1996 Aug;16(4):265-9 [8875241.001]
  • [Cites] J Neurosurg. 1997 May;86(5):793-800 [9126894.001]
  • [Cites] J Neuropathol Exp Neurol. 1997 Aug;56(8):879-86 [9258258.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):427-36 [9308947.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] DNA Res. 1997 Oct 31;4(5):345-9 [9455484.001]
  • [Cites] J Neurooncol. 1998 Apr;37(2):177-88 [9524097.001]
  • [Cites] Cancer Genet Cytogenet. 1998 Jun;103(2):95-100 [9614906.001]
  • [Cites] Cancer Res. 1998 Aug 1;58(15):3226-30 [9699646.001]
  • [Cites] Nat Genet. 1998 Oct;20(2):207-11 [9771718.001]
  • [Cites] Neurol Res. 1998 Oct;20(7):612-6 [9785589.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 [9843981.001]
  • [Cites] Cancer. 1999 May 1;85(9):2046-56 [10223247.001]
  • [Cites] J Neurooncol. 1999 Jan;41(2):167-74 [10222437.001]
  • [Cites] Mol Carcinog. 1999 Apr;24(4):300-4 [10326867.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(9):921-32 [10526073.001]
  • [Cites] Mol Cell Biol. 2005 Jan;25(2):612-20 [15632063.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):183-202 [15674477.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):809-16 [15708260.001]
  • [Cites] Neuropathol Appl Neurobiol. 2005 Apr;31(2):141-9 [15771707.001]
  • [Cites] Cancer Res. 2005 Apr 1;65(7):2653-61 [15805262.001]
  • [Cites] Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2070-9 [16609018.001]
  • [Cites] Leukemia. 2006 Nov;20(11):2034-40 [17024118.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Jan;47(1):43-55 [17943972.001]
  • [Cites] Clin Cancer Res. 2007 Dec 1;13(23):7022-8 [18056178.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12 [18077431.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2008 May;79(5):574-80 [17766430.001]
  • [Cites] Neurosurg Focus. 2008;24(5):E3 [18447742.001]
  • [Cites] Neuro Oncol. 2009 Apr;11(2):192-200 [18923191.001]
  • [Cites] Br J Cancer. 2002 Jun 5;86(11):1763-9 [12087464.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):57-61 [10656373.001]
  • [Cites] Adv Anat Pathol. 2000 May;7(3):153-7 [10809221.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Jul 1;120(1):30-6 [10913674.001]
  • [Cites] J Neurooncol. 2000 Jun;48(2):151-60 [11083080.001]
  • [Cites] Am J Pathol. 2001 Feb;158(2):393-8 [11159177.001]
  • [Cites] Am J Pathol. 2001 Aug;159(2):661-9 [11485924.001]
  • [Cites] Cancer Genet Cytogenet. 2001 Aug;129(1):88-91 [11520574.001]
  • [Cites] Cytogenet Cell Genet. 2001;93(3-4):207-20 [11528114.001]
  • [Cites] Behav Brain Res. 2001 Nov 1;125(1-2):279-84 [11682119.001]
  • [Cites] Nat Genet. 2002 Oct;32(2):316-20 [12355089.001]
  • (PMID = 19918127.001).
  • [ISSN] 1554-6578
  • [Journal-full-title] Journal of neuropathology and experimental neurology
  • [ISO-abbreviation] J. Neuropathol. Exp. Neurol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / T32CA09216; United States / NCI NIH HHS / CA / R21 CA106695; United States / NCI NIH HHS / CA / R33 CA106695-03; United States / NCI NIH HHS / CA / T32 CA009216-28; United States / NCI NIH HHS / CA / CA009216-28; United States / NCI NIH HHS / CA / T32 CA009216; United States / NCI NIH HHS / CA / CA106695-03; United States / NCI NIH HHS / CA / R21 CA106695-02; United States / NCI NIH HHS / CA / R33 CA106695; United States / NCI NIH HHS / CA / CA106695-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS187123; NLM/ PMC2847373
  •  go-up   go-down


52. Amoli FA, Mehrabani PM, Tari AS: Aggressive orbital optic nerve meningioma with benign microscopic features: a case report. Orbit; 2007 Dec;26(4):271-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive orbital optic nerve meningioma with benign microscopic features: a case report.
  • Primary optic nerve meningiomas occur at lower ages than meningiomas arising from the coverings of the brain and spinal cord.
  • Here we report the case of a 20-year-old female with an aggressive orbital meningioma referred to the Ophthalmology Department of the Farabi Hospital in Tehran.
  • The patient had a history of orbital meningioma from 10 years ago and several surgical resections due to tumor recurrence during these 10 years.
  • Microscopic study showed meningotheliomatous meningioma with extensive involvement of the optic nerve and invasion of the optic disc, sclera and choroid.
  • [MeSH-major] Meningioma / pathology. Optic Nerve Neoplasms / pathology
  • [MeSH-minor] Adult. Combined Modality Therapy. Female. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18097966.001).
  • [ISSN] 0167-6830
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


53. Miyatake S, Kajimoto Y, Kuroiwa T: [Intraoperative photo-dynamic diagnosis of brain tumors]. Brain Nerve; 2009 Jul;61(7):835-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intraoperative photo-dynamic diagnosis of brain tumors].
  • Approximately 80% to 90% of the malignant gliomas show this red fluorescence in surgery as mentioned above, while only a limited number of metastatic brain tumor cases do.
  • In the surgery for metastatic brain tumor and lesionectomy for radiation necrosis and neurodegenerative disease, white matter around the lesion showed vague fluorescence, which also provided us with a hallmark in the surgery.
  • Additionally, in meningioma, some tumors showed the red fluorescence, which is especially helpful in the removal of the infiltrative portion in the bone and normal parenchyma.
  • [MeSH-major] Aminolevulinic Acid. Brain Neoplasms / diagnosis. Brain Neoplasms / surgery. Glioma / diagnosis. Glioma / surgery
  • [MeSH-minor] Adult. Aged. Female. Fluorescence. Humans. Intraoperative Period. Meningeal Neoplasms / surgery. Meningioma / surgery. Microsurgery. Neurosurgical Procedures. Protoporphyrins. Surgery, Computer-Assisted. Ultraviolet Rays

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19618861.001).
  • [ISSN] 1881-6096
  • [Journal-full-title] Brain and nerve = Shinkei kenkyū no shinpo
  • [ISO-abbreviation] Brain Nerve
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Protoporphyrins; 553-12-8 / protoporphyrin IX; 88755TAZ87 / Aminolevulinic Acid
  • [Number-of-references] 17
  •  go-up   go-down


54. Michael DB, Byers DM, Irwin LN: Gene expression following traumatic brain injury in humans: analysis by microarray. J Clin Neurosci; 2005 Apr;12(3):284-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gene expression following traumatic brain injury in humans: analysis by microarray.
  • Global changes in gene expression were analyzed in pericontusional tissue taken during surgery from 4 patients with traumatic brain injury (TBI), in cerebral infarction tissue from a patient with vasculitis and in normal brain tissue resected during craniotomy for meningioma.
  • [MeSH-major] Brain Injuries / genetics. Brain Injuries / metabolism. Gene Expression / physiology
  • [MeSH-minor] Adult. Alcohol Drinking / metabolism. Apoptosis / drug effects. Apoptosis / genetics. Cell Cycle / drug effects. Cell Cycle / genetics. Cell Differentiation / drug effects. Central Nervous System Depressants / pharmacology. Data Interpretation, Statistical. Early Growth Response Protein 1 / biosynthesis. Early Growth Response Protein 1 / genetics. Ethanol / pharmacology. Female. Genes, fos / genetics. HSP70 Heat-Shock Proteins / biosynthesis. HSP70 Heat-Shock Proteins / genetics. Humans. Male. Middle Aged. Oligonucleotide Array Sequence Analysis. Proto-Oncogene Proteins c-jun / biosynthesis. Proto-Oncogene Proteins c-jun / genetics. RNA / genetics. RNA / isolation & purification. Signal Transduction / drug effects. Signal Transduction / genetics. Up-Regulation

  • COS Scholar Universe. author profiles.
  • GeneWeaver. GeneWeaver .
  • Hazardous Substances Data Bank. ETHANOL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15851083.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / G12 RR08124; United States / NIDCD NIH HHS / DC / R15 DC005179
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Central Nervous System Depressants; 0 / EGR1 protein, human; 0 / Early Growth Response Protein 1; 0 / HSP70 Heat-Shock Proteins; 0 / Proto-Oncogene Proteins c-jun; 3K9958V90M / Ethanol; 63231-63-0 / RNA
  •  go-up   go-down


55. Samkange-Zeeb F, Schlehofer B, Schüz J, Schlaefer K, Berg-Beckhoff G, Wahrendorf J, Blettner M: Occupation and risk of glioma, meningioma and acoustic neuroma: results from a German case-control study (interphone study group, Germany). Cancer Epidemiol; 2010 Feb;34(1):55-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Occupation and risk of glioma, meningioma and acoustic neuroma: results from a German case-control study (interphone study group, Germany).
  • BACKGROUND: Several epidemiological studies have investigated the association between occupation and brain tumour risk, but results have been inconclusive.
  • We investigated the association between six occupational categories defined a priori: chemical, metal, agricultural, construction, electrical/electronic and transport, and the risk of glioma, meningioma and acoustic neuroma.
  • RESULTS: Most of the observed odds ratios were close to 1.0 for ever having worked in the six occupational sectors and risk of glioma, meningioma and acoustic neuroma.
  • CONCLUSIONS: We did not observe an increased risk of glioma or meningioma for occupations in the agricultural, construction, transport, chemical, electrical/electronic and metal sectors.
  • [MeSH-major] Brain Neoplasms / epidemiology. Glioma / epidemiology. Meningeal Neoplasms / epidemiology. Meningioma / epidemiology. Neuroma, Acoustic / epidemiology. Occupational Diseases / epidemiology
  • [MeSH-minor] Adult. Aged. Case-Control Studies. Female. Germany / epidemiology. Humans. Male. Middle Aged. Occupational Exposure / analysis. Occupations / classification. Risk Assessment. Risk Factors


56. Cappabianca P, Esposito F, Esposito I, Cavallo LM, Leone CA: Use of a thrombin-gelatin haemostatic matrix in endoscopic endonasal extended approaches: technical note. Acta Neurochir (Wien); 2009 Jan;151(1):69-77; discussion 77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenoma / pathology. Adenoma / surgery. Adult. Aged. Brain Neoplasms / pathology. Brain Neoplasms / surgery. Craniopharyngioma / pathology. Craniopharyngioma / surgery. Female. Humans. Intraoperative Complications / drug therapy. Intraoperative Complications / etiology. Intraoperative Complications / prevention & control. Male. Meningeal Neoplasms / pathology. Meningeal Neoplasms / surgery. Meningioma / pathology. Meningioma / surgery. Middle Aged. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery. Skull Base Neoplasms / pathology. Skull Base Neoplasms / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19129962.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Austria
  • [Chemical-registry-number] 0 / FloSeal Matrix
  •  go-up   go-down


57. Jabbour SK, Zhang Z, Arnold D, Wharam MD: Risk of second tumor in intracranial germinoma patients treated with radiation therapy: the Johns Hopkins experience. J Neurooncol; 2009 Jan;91(2):227-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One developed a benign falcine meningioma.
  • [MeSH-minor] Adolescent. Adult. Brain Neoplasms / radiotherapy. Child. Combined Modality Therapy. Female. Follow-Up Studies. Germinoma / radiotherapy. Humans. Incidence. Male. Retrospective Studies. Risk Assessment. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Germinoma.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2007 Apr 20;25(12):1532-8 [17442996.001]
  • [Cites] Pediatr Blood Cancer. 2006 Jul;47(1):83-8 [16317732.001]
  • [Cites] J Neurosurg. 1998 Jan;88(1):66-72 [9420074.001]
  • [Cites] Cancer. 1997 Nov 1;80(9):1792-7 [9351549.001]
  • [Cites] J Natl Cancer Inst. 1989 Dec 20;81(24):1874-8 [2556586.001]
  • [Cites] Intern Med. 2000 Nov;39(11):920-4 [11065243.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):618-29 [11309438.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):65-73 [10924973.001]
  • [Cites] J Neurooncol. 2004 Oct;70(1):83-5 [15527112.001]
  • [Cites] Lung Cancer. 2007 Sep;57(3):410-3 [17475364.001]
  • [Cites] Pediatr Blood Cancer. 2007 Apr;48(4):453-9 [16767718.001]
  • [Cites] Neuropediatrics. 2005 Apr;36(2):71-7 [15822019.001]
  • [Cites] J Clin Oncol. 2007 Jul 1;25(19):2833-9 [17602088.001]
  • [Cites] J Clin Oncol. 1999 Aug;17(8):2585-92 [10561326.001]
  • [Cites] Ann Neurol. 1998 Sep;44(3):313-6 [9749596.001]
  • [Cites] Eur J Cancer. 1998 Jan;34(1):104-10 [9624246.001]
  • [Cites] N Engl J Med. 1988 Oct 20;319(16):1033-9 [3173432.001]
  • [Cites] Cancer Causes Control. 1997 Nov;8(6):865-71 [9427429.001]
  • [Cites] Ann Oncol. 1999 Jun;10(6):723-6 [10442196.001]
  • [Cites] Urol Oncol. 2001 Mar;6(2):49-52 [11166620.001]
  • [Cites] Lab Invest. 1989 Jan;60(1):14-21 [2536126.001]
  • [Cites] Cancer. 2006 Dec 1;107(11):2741-2; author reply 2742 [17039496.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):511-8 [12738328.001]
  • [Cites] Pediatr Blood Cancer. 2007 Sep;49(3):294-7 [17243137.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1165-70 [15001260.001]
  • [Cites] J Clin Pathol. 1994 Aug;47(8):771-2 [7962639.001]
  • [Cites] Ann Oncol. 2005 May;16(5):793-7 [15802277.001]
  • [Cites] Cancer. 2005 Jul 1;104(1):126-34 [15895370.001]
  • [Cites] J Clin Oncol. 2004 Mar 1;22(5):846-53 [14990640.001]
  • [Cites] J Clin Oncol. 1996 Nov;14(11):2908-15 [8918487.001]
  • [Cites] Pediatr Blood Cancer. 2006 Jul;47(1):77-82 [16047364.001]
  • [Cites] J Natl Cancer Inst. 2005 Sep 21;97(18):1354-65 [16174857.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):419-26 [9308946.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1171-6 [10725628.001]
  • (PMID = 18813873.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. El Ayachi I, Baeza N, Fernandez C, Colin C, Scavarda D, Pesheva P, Figarella-Branger D: KIAA0510, the 3'-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas. Neuropathol Appl Neurobiol; 2010 Aug;36(5):399-410
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We also analysed a large series of various brain tumours and found that in the group of astrocytic tumours, tenascin-R expression decreased with malignancy, whereas oligodendrogliomas sometimes retained a high level of tenascin-R even in high-grade tumours.
  • In normal brain, tenascin-R was exclusively expressed by normal oligodendrocytes and subsets of neurones during post-natal development and in adulthood, where it could differentially affect cellular adhesiveness and/or differentiation.
  • Whether tenascin-R overexpression negatively influences brain invasion remains to be determined.
  • [MeSH-minor] 3' Untranslated Regions / genetics. Adolescent. Adult. Aged. Child. Child, Preschool. Ependymoma / genetics. Ependymoma / physiopathology. Ganglioglioma / genetics. Ganglioglioma / physiopathology. Humans. Infant. Meningeal Neoplasms / genetics. Meningeal Neoplasms / physiopathology. Meningioma / genetics. Meningioma / physiopathology. Middle Aged. Supratentorial Neoplasms / genetics. Supratentorial Neoplasms / physiopathology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20202125.001).
  • [ISSN] 1365-2990
  • [Journal-full-title] Neuropathology and applied neurobiology
  • [ISO-abbreviation] Neuropathol. Appl. Neurobiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Tenascin; 147604-77-1 / tenascin R
  •  go-up   go-down


59. Sakuma T, Nakagawa T, Ido K, Takeuchi H, Sato K, Kubota T: Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas. J Neurooncol; 2008 Jun;88(2):143-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We studied the expression of vascular endothelial growth factor-A (VEGF-A) and mRNA stability factor HuR in 40 supratentorial meningiomas using RT-PCR, ELISA and immunohistochemistry, and analyzed their associations with the clinicopathological characteristics, including microvascular density (MVD), peritumoral brain edema (PTBE), histological subtypes and grades, and the performance of preoperative arterial embolization.
  • Furthermore, we investigated the involvement of HuR in the upregulation of VEGF-A expression using primary meningioma cell cultures.
  • HuR expression was correlated positively with VEGF-A expression in meningioma tissues.
  • In in vitro experiments, hypoxia induced the upregulation of VEGF-A expression and the cytoplasmic translocation of HuR protein in meningioma cells, and inhibition of the cytoplasmic translocation of HuR reduced the upregulation of VEGF-A expression in meningioma cells.
  • [MeSH-major] Antigens, Surface / genetics. Antigens, Surface / metabolism. Meningioma / metabolism. RNA, Messenger / metabolism. RNA-Binding Proteins / genetics. RNA-Binding Proteins / metabolism. Vascular Endothelial Growth Factor A / genetics. Vascular Endothelial Growth Factor A / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Analysis of Variance. Angiography. Antibiotics, Antineoplastic / pharmacology. Antigens, CD34 / metabolism. Brain Edema / etiology. Cell Line, Tumor. Dose-Response Relationship, Drug. ELAV Proteins. ELAV-Like Protein 1. Enzyme-Linked Immunosorbent Assay / methods. Fatty Acids, Unsaturated / pharmacology. Female. Gene Expression Regulation, Neoplastic / drug effects. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Oxygen / pharmacology

  • Hazardous Substances Data Bank. OXYGEN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Gastroenterol. 2006 Aug 21;12(31):4937-42 [16937487.001]
  • [Cites] J Neurosurg. 2002 Sep;97(3):658-67 [12296651.001]
  • [Cites] Neurosurgery. 2001 Nov;49(5):1046-51; discussion 1051-2 [11846896.001]
  • [Cites] Neurosurgery. 2002 Jul;51(1):183-92; discussion 192-3 [12182416.001]
  • [Cites] Folia Neuropathol. 2003;41(3):149-53 [14604296.001]
  • [Cites] J Neurooncol. 2002 Dec;60(3):235-45 [12510775.001]
  • [Cites] Acta Neurochir (Wien). 1998;140(4):333-40 [9689324.001]
  • [Cites] J Pathol. 1999 Sep;189(1):66-71 [10451490.001]
  • [Cites] Clinics (Sao Paulo). 2005 Jun;60(3):201-6 [15962080.001]
  • [Cites] Clin Neuropathol. 1988 May-Jun;7(3):105-10 [3060289.001]
  • [Cites] Neurosurgery. 1997 May;40(5):1016-26 [9149260.001]
  • [Cites] J Neurochem. 2005 Oct;95(1):99-110 [16042757.001]
  • [Cites] Neuropathol Appl Neurobiol. 2004 Apr;30(2):118-25 [15043709.001]
  • [Cites] Acta Neuropathol. 2007 Aug;114(2):97-109 [17618441.001]
  • [Cites] Neurosurgery. 2000 Apr;46(4):938-47; discussion 947-8 [10764269.001]
  • [Cites] Mediators Inflamm. 2006;2006(6):36376 [17392584.001]
  • [Cites] J Clin Neurosci. 2005 Sep;12(7):750-3 [16165364.001]
  • [Cites] Neurosurgery. 1997 Jun;40(6):1269-77 [9179901.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):7591-4 [14633672.001]
  • [Cites] J Neurosurg. 1997 Sep;87(3):368-73 [9285600.001]
  • [Cites] Virchows Arch. 2006 Nov;449(5):546-53 [17013629.001]
  • [Cites] Clin Cancer Res. 2005 Oct 15;11(20):7362-8 [16243808.001]
  • [Cites] J Neurosurg. 1996 Dec;85(6):1095-101 [8929501.001]
  • [Cites] RNA Biol. 2005 Jan;2(1):11-3 [17132932.001]
  • [Cites] J Neurooncol. 2002 Nov;60(2):159-64 [12635663.001]
  • [Cites] Acta Neurochir (Wien). 1997;139(12):1136-42 [9479419.001]
  • [Cites] J Oral Pathol Med. 2007 May;36(5):297-303 [17448140.001]
  • [Cites] Neurosci Lett. 2000 Mar 31;283(1):45-8 [10729630.001]
  • [Cites] Cancer. 1999 Feb 15;85(4):936-44 [10091773.001]
  • [Cites] J Biol Chem. 1996 Feb 2;271(5):2746-53 [8576250.001]
  • [Cites] Cancer. 2000 Sep 1;89(5):1102-10 [10964341.001]
  • [Cites] Cancer Res. 2004 Jan 1;64(1):189-95 [14729623.001]
  • [Cites] J Neurooncol. 2004 Dec;70(3):349-57 [15662977.001]
  • [Cites] Tumori. 2003 Mar-Apr;89(2):136-40 [12841659.001]
  • [Cites] J Neurooncol. 2007 Mar;82(1):63-8 [17225937.001]
  • [Cites] Cancer Res. 1995 Mar 1;55(5):1189-93 [7532545.001]
  • [Cites] Magn Reson Med Sci. 2003 Dec 31;2(4):171-9 [16222111.001]
  • [Cites] Clin Cancer Res. 2007 Jan 1;13(1):68-75 [17200340.001]
  • [Cites] Cancer Res. 2001 Mar 1;61(5):2154-61 [11280780.001]
  • [Cites] Cancer Res. 2005 Mar 15;65(6):2157-61 [15781626.001]
  • [Cites] Acta Neuropathol. 1997 Feb;93(2):109-17 [9039457.001]
  • [Cites] Clin Imaging. 2002 Jul-Aug;26(4):243-9 [12140153.001]
  • (PMID = 18317686.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Antigens, CD34; 0 / Antigens, Surface; 0 / ELAV Proteins; 0 / ELAV-Like Protein 1; 0 / ELAVL1 protein, human; 0 / Fatty Acids, Unsaturated; 0 / RNA, Messenger; 0 / RNA-Binding Proteins; 0 / Vascular Endothelial Growth Factor A; S88TT14065 / Oxygen; Y031I2N1EO / leptomycin B
  •  go-up   go-down


60. Anton T, Guttierez J, Rock J: Tentorial schwannoma: a case report and review of the literature. J Neurooncol; 2006 Feb;76(3):307-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Meningioma / pathology. Neurosurgical Procedures. Tomography, X-Ray Computed. Trigeminal Nerve / pathology

  • Genetic Alliance. consumer health - Schwannoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosurg Rev. 1996;19(4):269-74 [9007892.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1958 May;21(2):92-4 [13539649.001]
  • [Cites] Acta Neurochir Suppl (Wien). 1991;53:166-70 [1803875.001]
  • [Cites] Am J Ophthalmol. 1999 Feb;127(2):183-8 [10030561.001]
  • [Cites] Br J Radiol. 2003 Jun;76(906):421-4 [12814930.001]
  • [Cites] Acta Neurochir (Wien). 1997;139(8):756-60 [9309291.001]
  • [Cites] Br J Neurosurg. 1994;8(2):219-23 [7917097.001]
  • [Cites] J Neurosurg. 1990 Nov;73(5):777-81 [2213169.001]
  • [Cites] Surg Neurol. 1984 Oct;22(4):360-4 [6433498.001]
  • [Cites] No Shinkei Geka. 1991 Jan;19(1):47-51 [2000157.001]
  • [Cites] Brain. 1970;93(3):475-90 [4097005.001]
  • [Cites] Neurosurgery. 1997 Jan;40(1):194-7 [8971843.001]
  • [Cites] Br J Neurosurg. 1999 Apr;13(2):212-3 [10616595.001]
  • [Cites] No Shinkei Geka. 1992 Nov;20(11):1189-94 [1448194.001]
  • [Cites] Surg Neurol. 1990 Sep;34(3):160-3 [2385823.001]
  • [Cites] No Shinkei Geka. 1974 Sep;2(9):643-7 [4477644.001]
  • [Cites] Neurosurgery. 2002 Jun;50(6):1352-5 [12015855.001]
  • [Cites] Pediatr Neurosurg. 2003 Apr;38(4):167-73 [12646734.001]
  • [Cites] Neurology. 1972 Jul;22(7):726-31 [4673254.001]
  • [Cites] Pediatr Neurosurg. 2002 Mar;36(3):153-6 [11919450.001]
  • [Cites] J Neuropathol Exp Neurol. 1971 Oct;30(4):603-12 [5135015.001]
  • (PMID = 16200344.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. El Shehaby A, Ganz JC, Reda WA, Hafez A: Mechanisms of edema after gamma knife surgery for meningiomas. Report of two cases. J Neurosurg; 2005 Jan;102 Suppl:1-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The authors describe two patients in whom tumor swelling and brain swelling (and possible tumor swelling), respectively, developed after undergoing gamma knife surgery.
  • [MeSH-major] Brain Edema / etiology. Meningeal Neoplasms / surgery. Meningioma / surgery. Postoperative Complications. Radiosurgery / instrumentation
  • [MeSH-minor] Adolescent. Adult. Anti-Inflammatory Agents / therapeutic use. Anticonvulsants / therapeutic use. Dexamethasone / therapeutic use. Epilepsy / etiology. Humans. Magnetic Resonance Imaging. Male. Phenytoin / therapeutic use

  • Genetic Alliance. consumer health - Edema.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • Hazardous Substances Data Bank. PHENYTOIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15662770.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 0 / Anticonvulsants; 6158TKW0C5 / Phenytoin; 7S5I7G3JQL / Dexamethasone
  •  go-up   go-down


62. Zeidman LA, Ankenbrandt WJ, Du H, Paleologos N, Vick NA: Growth rate of non-operated meningiomas. J Neurol; 2008 Jun;255(6):891-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Meningiomas are dural-based brain tumors that are typically histologically benign.
  • METHODS: Twenty-one patients (with 22 tumors) had serial MRI brain scans available for review.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningeal Neoplasms / physiopathology. Meninges / pathology. Meninges / physiopathology. Meningioma / pathology. Meningioma / physiopathology
  • [MeSH-minor] Adult. Aged. Brain / pathology. Brain / physiopathology. Cell Proliferation. Cerebellopontine Angle / pathology. Cerebellopontine Angle / physiopathology. Cerebellopontine Angle / surgery. Cerebrum / pathology. Cerebrum / physiopathology. Disease Progression. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Invasiveness / physiopathology. Neurosurgical Procedures. Retrospective Studies. Time. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 2000 May;92(5):766-70 [10794289.001]
  • [Cites] J Neurosurg. 1995 Aug;83(2):222-4 [7616265.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(5):507-11 [10898357.001]
  • [Cites] Neurology. 2004 Sep 28;63(6):1133-4 [15452322.001]
  • [Cites] Neurosurgery. 2003 Jul;53(1):62-70; discussion 70-1 [12823874.001]
  • [Cites] J Neurosurg. 1990 Oct;73(4):545-7 [2398385.001]
  • [Cites] Neurology. 1997 May;48(5):1459-62 [9153494.001]
  • [Cites] Neurology. 1998 Dec;51(6):1718-20 [9855530.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2000 Jan;68(1):25-8 [10601396.001]
  • [Cites] Stroke. 1996 Aug;27(8):1304-5 [8711791.001]
  • (PMID = 18350353.001).
  • [ISSN] 0340-5354
  • [Journal-full-title] Journal of neurology
  • [ISO-abbreviation] J. Neurol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


63. Simis A, Pires de Aguiar PH, Leite CC, Santana PA Jr, Rosemberg S, Teixeira MJ: Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence. Surg Neurol; 2008 Nov;70(5):471-7; discussion 477
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence.
  • METHODS: Sixty-one patients with benign meningiomas were chosen for surgical treatment by the Group of Brain Tumors and Metastasis of the Department of Neurosurgery.
  • CONCLUSION: Peritumoral brain edema may be related to the invading potential of meningiomas and may play a role in the recurrence potential of the tumor.
  • [MeSH-major] Brain Edema / complications. Meningeal Neoplasms / pathology. Meningeal Neoplasms / surgery. Meningioma / pathology. Meningioma / surgery. Neoplasm Recurrence, Local / etiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Risk Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Edema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18586307.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. van Westen D, Lätt J, Englund E, Brockstedt S, Larsson EM: Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy. Acta Radiol; 2006 Apr;47(3):311-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy.
  • ADC and FA were determined from ROIs placed in peritumoral areas with T2-signal changes, adjacent normal appearing white matter (NAWM), and corresponding areas in the contralateral healthy brain.
  • Values and lesion-to-brain ratios from gliomas were compared to those from meningiomas and metastases.
  • RESULTS: Values and lesion-to-brain ratios of ADC and FA in peritumoral areas with T2-signal changes did not differ between gliomas, meningiomas, and metastases (P = 0.40, P = 0.40, P = 0.61, P = 0.34).
  • Values of ADC and FA and the lesion-to-brain ratio of FA in the adjacent NAWM did not differ between tumor types (P = 0.74, P = 0.25, and P = 0.31).
  • The lesion-to-brain ratio of ADC in the adjacent NAWM was higher in gliomas than in meningiomas and metastases (P = 0.004), but overlapped between tumor types.
  • CONCLUSION: Values and lesion-to-brain ratios of ADC and FA in areas with T2-signal changes surrounding intracranial tumors and adjacent NAWM were not helpful for distinguishing pure edema from tumor-infiltrated edema when data from gliomas, meningiomas, and metastases were compared.
  • [MeSH-major] Brain Edema / pathology. Brain Neoplasms / pathology. Diffusion Magnetic Resonance Imaging. Glioma / pathology. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Anisotropy. Diagnosis, Differential. Diffusion. Female. Humans. Male. Middle Aged. Prospective Studies

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Acta Radiol. 2006 Apr;47(3):230 [16613301.001]
  • (PMID = 16613314.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Sweden
  •  go-up   go-down


65. Shirai W, Tokumitsu N, Sako K, Takahashi T: [Hemangiopericytoma at the transverse sinus presenting with intracerebral hemorrhage: case report]. No Shinkei Geka; 2005 Sep;33(9):895-900
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Based on the findings shown in this case report, hemangiopericytoma should be included in the differential diagnosis from benign meningioma.
  • [MeSH-major] Brain Neoplasms / surgery. Cerebral Hemorrhage / etiology. Hemangiopericytoma / surgery
  • [MeSH-minor] Adult. Cranial Sinuses. Female. Humans

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16164186.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


66. Kashiwazaki D, Hida K, Yano S, Seki T, Iwasaki Y: Subpial hemangiopericytoma with marked extramedullary growth: case report. Neurosurgery; 2007 Dec;61(6):E1336-7; discussion E1337
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Central nervous system hemangiopericytomas occur primarily in the epidural space of the brain and spinal cord.
  • Differential diagnoses include hemangioblastoma, meningioma, schwannoma, and solitary fibrous tumor, the clinical course and prognosis of which are different from hemangiopericytoma.
  • [MeSH-minor] Adult. Disease Progression. Humans. Magnetic Resonance Imaging / methods. Male

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18162866.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Liu Y, Tian RF, Li YM, Liu WP, Cao L, Yang XL, Cao WD, Zhang X: The expression of seven 14-3-3 isoforms in human meningioma. Brain Res; 2010 Jun 8;1336:98-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The expression of seven 14-3-3 isoforms in human meningioma.
  • 14-3-3 proteins comprise a large family of highly conserved, acidic polypeptides, expressed in all eukaryotic organisms, with highest concentration found in the brain.
  • However, the expression of seven 14-3-3 isoforms in meningioma still remains unknown.
  • This study is the first examination of 14-3-3 isoforms in three grades of meningioma by immunohistochemistry.
  • 14-3-3epsilon, zeta and theta were specifically expressed in meningioma, and their expression levels increased with the increase of pathological grade of meningioma.
  • The 14-3-3 eta, beta, gamma and sigma isoforms were negatively expressed in meningioma.
  • In conclusion, The 14-3-3 epsilon, zeta and theta may be involved in tumorigenesis of meningioma and be efficient markers for predicting the degree of malignancy in meningioma.
  • [MeSH-major] 14-3-3 Proteins / biosynthesis. Meningeal Neoplasms / metabolism. Meningeal Neoplasms / pathology. Meningioma / metabolism. Meningioma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / analysis. Child. Female. Humans. Immunohistochemistry. Male. Middle Aged. Protein Isoforms / biosynthesis. Young Adult

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier B.V. All rights reserved.
  • (PMID = 20388496.001).
  • [ISSN] 1872-6240
  • [Journal-full-title] Brain research
  • [ISO-abbreviation] Brain Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / 14-3-3 Proteins; 0 / Biomarkers, Tumor; 0 / Protein Isoforms
  •  go-up   go-down


68. Marton E, Bonaldi L, Busato S, Longatti P: Atypical meningioma in Werner syndrome: a case report. J Neurooncol; 2006 Sep;79(2):181-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Atypical meningioma in Werner syndrome: a case report.
  • INTRODUCTION: Werner Syndrome, or adult progeria, is a rare autosomal recessive disorder caused by a mutation in the Werner Syndrome Gene belonging to the family of RecQ helicase.
  • CLINICAL PRESENTATION: We present the case of a 46-year-old man with Werner Syndrome and a convexity meningioma.
  • Histological examination revealed an atypical meningioma.
  • CONCLUSION: 1p deletion correlates with meningioma progression and in this case correlates with histological examination.
  • [MeSH-major] Brain Neoplasms / complications. Chromosomes, Human, Pair 22 / genetics. Meningioma / complications. Monosomy / diagnosis. Werner Syndrome / complications

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - Werner's syndrome.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosurgery. 2004 May;54(5):1263-6; discussion 1266-7 [15113484.001]
  • [Cites] No To Shinkei. 1994 Nov;46(11):1069-74 [7873280.001]
  • [Cites] J Orthop Surg (Hong Kong). 2003 Dec;11(2):224-33 [14676353.001]
  • [Cites] Neurobiol Aging. 1996 May-Jun;17(3):325-30 [8725892.001]
  • [Cites] Nat Genet. 2004 Aug;36(8):877-82 [15235603.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):239-46 [8722214.001]
  • [Cites] J Clin Neurosci. 2005 May;12(4):503-6 [15925797.001]
  • [Cites] Cytogenet Cell Genet. 2001;93(3-4):207-20 [11528114.001]
  • [Cites] No Shinkei Geka. 1988 Feb;16(2):189-94 [3285233.001]
  • [Cites] Clin Genet. 1981 Jan;19(1):8-15 [7460386.001]
  • [Cites] Neurosurgery. 1980 Nov;7(5):517-20 [7003435.001]
  • [Cites] Br J Dermatol. 1997 Apr;136(4):620-3 [9155973.001]
  • [Cites] Dermatologica. 1989;178(2):118-20 [2924983.001]
  • [Cites] Carcinogenesis. 2003 May;24(5):791-802 [12771022.001]
  • [Cites] Gerontology. 2002 Jul-Aug;48(4):215-9 [12053110.001]
  • (PMID = 16598422.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Hirunwiwatkul P, Trobe JD, Blaivas M: Lymphoplasmacyte-rich meningioma mimicking idiopathic hypertrophic pachymeningitis. J Neuroophthalmol; 2007 Jun;27(2):91-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphoplasmacyte-rich meningioma mimicking idiopathic hypertrophic pachymeningitis.
  • Brain MRI showed meningeal thickening that involved the optic nerves and chiasm and enveloped and displaced the brainstem as far caudally as the foramen magnum.
  • The diffuse extensive nature of the lesion suggested an inflammatory process such as idiopathic hypertrophic pachymeningitis (IHP), but anterior temporal brain biopsy disclosed a relatively high proportion of meningothelial cells with islands of polyclonal inflammatory reaction consistent with a diagnosis of lymphoplasmacyte-rich meningioma (LRM), a rare variant.
  • [MeSH-major] Dura Mater / pathology. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Meningitis / diagnosis. Plasma Cells / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Hypertrophy. Magnetic Resonance Imaging. Male

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Meningitis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neuroophthalmol. 2007 Jun;27(2):89-90 [17548989.001]
  • (PMID = 17548990.001).
  • [ISSN] 1070-8022
  • [Journal-full-title] Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
  • [ISO-abbreviation] J Neuroophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


70. Hosler MR, Turbin RE, Cho ES, Wolansky LJ, Frohman LP: Idiopathic hypertrophic pachymeningitis mimicking lymphoplasmacyte-rich meningioma. J Neuroophthalmol; 2007 Jun;27(2):95-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Idiopathic hypertrophic pachymeningitis mimicking lymphoplasmacyte-rich meningioma.
  • A 28-year-old woman with a 6-year history of optic neuropathy and 8 years of hearing loss had enhancing dural lesions around the brain stem and in both internal auditory canals on MRI.
  • Histopathology from cranial procedures performed in 1990 and 1993 was originally interpreted as inflammatory meningioma, now known as lymphoplasmacyte-rich meningioma (LRM).
  • [MeSH-major] Dura Mater / pathology. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Meningitis / diagnosis. Plasma Cells / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Hypertrophy. Magnetic Resonance Imaging

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Meningitis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neuroophthalmol. 2007 Jun;27(2):89-90 [17548989.001]
  • (PMID = 17548991.001).
  • [ISSN] 1070-8022
  • [Journal-full-title] Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
  • [ISO-abbreviation] J Neuroophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


71. Nasseri K, Mills JR: Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005. Cancer Detect Prev; 2009;32(5-6):363-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005.
  • The purpose of this study was to compare the epidemiology of primary brain tumors in this ethnic population with the non-Hispanic, non-Middle Eastern White (NHNMW) in California.
  • Data for 683 cases of primary brain tumors (429 benign, 238 malignant, 16 uncertain) in the ME and 15,589 cases (8352 benign, 6812 malignant, 425 uncertain) in the NHNMW were available for this study.
  • Meningioma was the main histology responsible for the observed increase in patients over 40 years of age.
  • CONCLUSIONS: This study presents a significantly high incidence of benign meningioma in the ME population in California.
  • Considering the reported causal association of benign meningioma with childhood radiation exposure from Israel, exposure to this risk factor in this ethnic group needs to be evaluated in future studies.
  • [MeSH-major] Brain Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. California / epidemiology. Child. Child, Preschool. Continental Population Groups / statistics & numerical data. European Continental Ancestry Group / statistics & numerical data. Female. Humans. Incidence. Infant. Infant, Newborn. Male. Meningeal Neoplasms / epidemiology. Meningeal Neoplasms / ethnology. Meningioma / epidemiology. Meningioma / ethnology. Middle Aged. Middle East / ethnology. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):470-80 [18206397.001]
  • [Cites] Cancer Causes Control. 2008 Dec;19(10):1183-91 [18543070.001]
  • [Cites] Cancer Detect Prev. 2007;31(5):424-9 [18023539.001]
  • [Cites] Neuro Oncol. 1999 Jul;1(3):205-11 [11554389.001]
  • [Cites] Health Inf Manag. 1997 Mar-May;27(1):31-8 [10169442.001]
  • [Cites] Cancer. 2005 Dec 15;104(12):2798-806 [16288487.001]
  • [Cites] Neuro Oncol. 2002 Oct;4(4):278-99 [12356358.001]
  • [Cites] Am J Epidemiol. 2000 Feb 1;151(3):266-72 [10670551.001]
  • [Cites] Asian Pac J Cancer Prev. 2007 Jul-Sep;8(3):405-11 [18159978.001]
  • [Cites] Neuroepidemiology. 1989;8(6):283-95 [2586698.001]
  • [Cites] Cancer Detect Prev. 2003;27(3):203-8 [12787727.001]
  • [Cites] Neoplasma. 2001;48(6):442-4 [11949834.001]
  • [Cites] Radiat Res. 2005 Apr;163(4):424-32 [15799699.001]
  • [Cites] Dermatol Surg. 2001 Jul;27(7):667-9 [11442620.001]
  • [Cites] Br J Surg. 1977 Jul;64(7):457-9 [922301.001]
  • [Cites] J Carcinog. 2005 Nov 10;4:21 [16283945.001]
  • [Cites] Calif Med. 1949 Mar;70(3):189-93 [18112454.001]
  • (PMID = 19588542.001).
  • [ISSN] 1525-1500
  • [Journal-full-title] Cancer detection and prevention
  • [ISO-abbreviation] Cancer Detect. Prev.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA103457; United States / NCI NIH HHS / PC / N01-PC-35139; United States / NCI NIH HHS / CA / R03 CA103457-02; United States / NCCDPHP CDC HHS / DP / U58 DP000807; United States / NCI NIH HHS / CA / N01PC54404; United States / NCI NIH HHS / CA / R03 CA103457; United States / NCI NIH HHS / CA / N01PC35136; United States / NCI NIH HHS / CA / N01PC35139; United States / NCI NIH HHS / PC / N01-PC-54404; United States / NCI NIH HHS / PC / N01-PC-35136; United States / NCCDPHP CDC HHS / DP / 1U58DP00807-01
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS140088; NLM/ PMC2785228
  •  go-up   go-down


72. Artico M, Bronzetti E, Pompili E, Ionta B, Alicino V, D'Ambrosio A, Santoro A, Pastore FS, Elenkov I, Fumagalli L: Immunohistochemical profile of neurotrophins in human cranial dura mater and meningiomas. Oncol Rep; 2009 Jun;21(6):1373-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The dural fragments were taken from the area of the craniotomy at least 8 cm from the lesion as well as from the area in which the meningioma had its dural attachment.
  • Our study revealed a general structural alteration of dural tissue due to the invasivity of meningiomatous lesions, together with an improved expression of brain derived neurotrophic factor (BDNF) in highly proliferating neoplastic cells and an evident production of nerve growth factor (NGF) in inflammatory cells, suggesting that BDNF has a role in supporting the proliferation rate of neoplastic cells, while NGF is involved in the activation of a chronic inflammatory response in neoplastic areas.
  • [MeSH-major] Dura Mater / chemistry. Immunohistochemistry. Meningeal Neoplasms / chemistry. Meningioma / chemistry. Nerve Growth Factors / analysis
  • [MeSH-minor] Adult. Aged. Brain-Derived Neurotrophic Factor / analysis. Craniotomy. Humans. Middle Aged. Nerve Growth Factor / analysis. RNA, Messenger / analysis. Receptors, Nerve Growth Factor / analysis. Reverse Transcriptase Polymerase Chain Reaction

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19424612.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Brain-Derived Neurotrophic Factor; 0 / Nerve Growth Factors; 0 / RNA, Messenger; 0 / Receptors, Nerve Growth Factor; 9061-61-4 / Nerve Growth Factor
  •  go-up   go-down


73. Sasayama T, Nishihara M, Tanaka K, Mizukawa K, Ehara K, Kanomata N, Kohmura E: Two metachronous tumors induced by radiation therapy: case report and review of the literature. J Neurooncol; 2008 Jul;88(3):315-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Various radiation-induced tumors, including meningioma, glioma, and sarcoma, have been reported; however, metachronous intracranial double tumors induced by radiation therapy are extremely rare.
  • At 24 years old, parasagittal meningioma developed in the left parietal region and was totally removed.
  • [MeSH-major] Astrocytoma / pathology. Brain Neoplasms / pathology. Meningeal Neoplasms / pathology. Meningioma / pathology. Neoplasms, Radiation-Induced / pathology. Neoplasms, Second Primary / pathology
  • [MeSH-minor] Adult. Age of Onset. Cerebellar Neoplasms / radiotherapy. Cranial Irradiation / adverse effects. Humans. In Situ Hybridization, Fluorescence. Infant. Loss of Heterozygosity. Magnetic Resonance Imaging. Male. Medulloblastoma / radiotherapy

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMJ. 1992 May 23;304(6838):1343-6 [1611331.001]
  • [Cites] Childs Nerv Syst. 2000 Jul;16(7):390-7 [10958546.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):65-73 [10924973.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):161-81 [15674476.001]
  • [Cites] Surg Neurol. 2003 Jul;60(1):60-7; discussion 67 [12865017.001]
  • [Cites] J Neurooncol. 2006 Mar;77(1):73-7 [16292489.001]
  • [Cites] J Neuropathol Exp Neurol. 2006 Oct;65(10):988-94 [17021403.001]
  • [Cites] J Neurosurg. 1998 Jan;88(1):111-5 [9420081.001]
  • [Cites] J Neurosurg. 2004 Jun;100(6):1002-13 [15200115.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):393-6 [9007876.001]
  • [Cites] Radiat Oncol. 2007 Jan 11;2:5 [17217530.001]
  • [Cites] Trends Genet. 2000 Apr;16(4):143-6 [10729825.001]
  • [Cites] Childs Nerv Syst. 2006 Sep;22(9):1201-7 [16570196.001]
  • [Cites] Cancer. 1993 Jun 15;71(12):4091-5 [8508374.001]
  • [Cites] N Engl J Med. 1988 Oct 20;319(16):1033-9 [3173432.001]
  • [Cites] Cancer Causes Control. 1997 Nov;8(6):865-71 [9427429.001]
  • [Cites] Neurosurgery. 1985 Sep;17(3):436-45 [2995867.001]
  • [Cites] Neurol Res. 2007 Oct;29(7):723-6 [17553214.001]
  • [Cites] Neurosurgery. 1995 Apr;36(4):685-90 [7596497.001]
  • [Cites] Acta Neurochir (Wien). 1998;140(8):763-70 [9810442.001]
  • [Cites] J Neurosurg. 1991 Oct;75(4):564-74 [1885974.001]
  • [Cites] J Neuropathol Exp Neurol. 2000 Jul;59(7):614-20 [10901233.001]
  • [Cites] J Neurosurg. 1995 Jul;83(1):154-62 [7782835.001]
  • [Cites] Cancer Lett. 1999 Jan 29;135(2):223-8 [10096432.001]
  • [Cites] J Neurosurg. 1989 Jul;71(1):77-82 [2661743.001]
  • [Cites] Neurosurgery. 1996 May;38(5):915-24; discussion 924-5 [8727816.001]
  • (PMID = 18373066.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Hope AJ, Mansur DB, Tu PH, Simpson JR: Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma. Childs Nerv Syst; 2006 Sep;22(9):1201-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma.
  • INTRODUCTION: Malignant brain tumors have been reported to occur after childhood irradiation more frequently than in the nonirradiated population.
  • DISCUSSION: In this study, we report the case of a 15-year-old boy treated for medulloblastoma with surgery and craniospinal radiotherapy, who developed a meningioma 18 years after initial treatment and subsequently an anaplastic astrocytoma 23 years after primary treatment.
  • The meningioma was resected without complications.
  • [MeSH-major] Astrocytoma / diagnosis. Cerebellar Neoplasms / radiotherapy. Cranial Irradiation / adverse effects. Medulloblastoma / radiotherapy. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Neoplasms, Radiation-Induced / diagnosis. Neoplasms, Second Primary / diagnosis
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biopsy. Chemotherapy, Adjuvant. Combined Modality Therapy. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Radiotherapy Dosage. Radiotherapy, Adjuvant. Reoperation. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Anaplastic Astrocytoma.
  • Genetic Alliance. consumer health - Medulloblastoma.
  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 1987 Dec;67(6):915-8 [2824720.001]
  • [Cites] J Clin Oncol. 1998 Dec;16(12):3761-7 [9850019.001]
  • [Cites] J Neurosurg. 1989 Mar;70(3):469-74 [2536806.001]
  • [Cites] Ann Neurol. 1978 Oct;4(4):319-21 [727737.001]
  • [Cites] Childs Nerv Syst. 2000 Jul;16(7):390-7 [10958546.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):618-29 [11309438.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):65-73 [10924973.001]
  • [Cites] Childs Nerv Syst. 2004 Apr;20(4):243-6 [14704813.001]
  • [Cites] Cancer. 1984 Feb 1;53(3):426-9 [6581853.001]
  • [Cites] Lancet. 1997 May 10;349(9062):1369 [9149706.001]
  • [Cites] J Pediatr Endocrinol Metab. 2003 Jan;16(1):97-101 [12585346.001]
  • [Cites] Surg Neurol. 2003 Jul;60(1):60-7; discussion 67 [12865017.001]
  • [Cites] Clin Neuropathol. 1994 Sep-Oct;13(5):281-5 [7805312.001]
  • [Cites] Cancer. 1998 Jan 1;82(1):8-34 [9428476.001]
  • [Cites] Pediatr Neurosurg. 1996 Oct;25(4):214-9 [9293548.001]
  • [Cites] J Neurosurg. 1998 Jan;88(1):111-5 [9420081.001]
  • [Cites] J Neurosurg. 1978 Apr;48(4):622-7 [632887.001]
  • [Cites] BMJ. 1993 Oct 23;307(6911):1030-6 [8251777.001]
  • [Cites] N Engl J Med. 1988 Oct 20;319(16):1033-9 [3173432.001]
  • [Cites] Cancer Causes Control. 1997 Nov;8(6):865-71 [9427429.001]
  • [Cites] Neurosurgery. 1995 Apr;36(4):685-90 [7596497.001]
  • [Cites] N Engl J Med. 1995 Mar 30;332(13):839-47 [7661930.001]
  • [Cites] Acta Neurochir (Wien). 2001;143(7):697-700 [11534690.001]
  • [Cites] J Neuroradiol. 1983;10 (1):43-9 [6864263.001]
  • [Cites] Neurology. 1981 May;31(5):616-9 [7194977.001]
  • [Cites] Neurosurgery. 1980 May;6(5):546-51 [6251397.001]
  • [Cites] Lancet. 1974 Feb 23;1(7852):277-9 [4130470.001]
  • [Cites] J Neurosurg. 1995 Jul;83(1):154-62 [7782835.001]
  • [Cites] Clin Neurol Neurosurg. 1998 Mar;100(1):56-9 [9637208.001]
  • [Cites] Can J Neurol Sci. 1984 Nov;11(4):475-8 [6518432.001]
  • [Cites] Arch Ophthalmol. 1988 Dec;106(12 ):1701-5 [3196211.001]
  • [Cites] Cancer. 1999 Jan 15;85(2):485-91 [10023719.001]
  • [Cites] Onkologie. 2001 Feb;24(1):66-72 [11441284.001]
  • [Cites] Eur J Paediatr Neurol. 1999;3(4):177-80 [10476368.001]
  • [Cites] Can J Neurol Sci. 1992 Nov;19(4):498-503 [1330262.001]
  • [Cites] J Neurosurg. 1978 Sep;49(3):445-9 [682008.001]
  • [Cites] Am J Public Health Nations Health. 1966 Dec;56(12):2114-20 [5334312.001]
  • [Cites] Cancer. 1979 Jan;43(1):129-36 [104784.001]
  • [Cites] J Pediatr Hematol Oncol. 2001 Oct;23(7):431-6 [11878577.001]
  • (PMID = 16570196.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 40
  •  go-up   go-down


75. Petrovic NS, Grujicic D, Artiko VM, Sobic-Saranovic DP, Gajic MM, Jaksic E, Grajic MM, Antonovic OJ, Petrovic MN, Obradovic VB: Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile. Nucl Med Commun; 2010 Nov;31(11):962-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
  • OBJECTIVES: (i) To examine blood perfusion and metabolic activity of various brain tumours using radionuclide cerebral angiography (RCA) and single-photon emission tomography (SPET) after a single dose of Tc-methoxyisobutylisonitrile (MIBI). (ii) To examine if the inclusion of RCA can improve insight into the relative contribution of tumour perfusion to the uptake of MIBI shown by SPET, and to improve evaluation of tumour biology. (iii) To determine the value and the roles of MIBI in the management of brain tumour patients.
  • METHODS: Fifty adult patients (38 male, 12 female) with a total of 56 intracranial space-occupying lesions have been included prospectively, 37 of which were newly diagnosed and the remaining with signs of recurrence/rest of earlier resected and irradiated brain tumours.
  • Regions of interest of the tumour and normal brain tissue were drawn on RCA and both early and delayed SPET slices.
  • The following tumour/brain activity ratios have been calculated: (i) tumour perfusion index (P);.
  • Analogous indices have been calculated from the same examinations performed in controls, reflecting maximal physiologic regional variations of perfusion and uptake in brain tissue.
  • RESULTS: Mean P of various brain tumours (low-grade gliomas 0.98, anaplastic gliomas 1.14, glioblastoma multiforme 1.20, metastases 1.09, lymphomas 1.08) differ little from each other and do not exceed maximal physiologic regional variations of cerebral perfusion (1.33), with the exception of meningioma (1.87, F=2.83, P=0.015).
  • The receiver operating characteristics curve analysis of P showed that for the cut-off value of 1.45 the sensitivity for distinguishing meningioma from other tumours is 75%, specificity 87%, positive predictive value 33% and negative predictive value 97%.
  • Mean E of malignant brain tumours (8.3, n=31, 23 primary, eight secondary), except anaplastic gliomas (3.5, n=5), differed significantly (P=0.02) from those of benign gliomas (3, n=9) but not from that of meningioma (11.9, n=4).
  • If the perfusion index is less than 1.45, then meningioma can be ruled out.
  • [MeSH-major] Brain Neoplasms / blood supply. Brain Neoplasms / metabolism. Cerebral Angiography. Cerebrovascular Circulation. Technetium Tc 99m Sestamibi / metabolism. Tomography, Emission-Computed, Single-Photon
  • [MeSH-minor] Adolescent. Adult. Aged. Biological Transport. Female. Follow-Up Studies. Humans. Male. Middle Aged. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20802363.001).
  • [ISSN] 1473-5628
  • [Journal-full-title] Nuclear medicine communications
  • [ISO-abbreviation] Nucl Med Commun
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 971Z4W1S09 / Technetium Tc 99m Sestamibi
  •  go-up   go-down


76. Purav P, Ganapathy K, Mallikarjuna VS, Annapurneswari S, Kalyanaraman S, Reginald J, Natarajan P, Bapu KR, Balamurugan M: Rosai-Dorfman disease of the central nervous system. J Clin Neurosci; 2005 Aug;12(6):656-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • When RDD involves the central nervous system the lesion simulates a meningioma.
  • [MeSH-major] Brain Diseases / pathology. Central Nervous System / pathology. Histiocytosis, Sinus / pathology
  • [MeSH-minor] Adolescent. Adult. Antigens, CD / metabolism. Antigens, Differentiation, Myelomonocytic / metabolism. Female. Follow-Up Studies. Humans. Immunohistochemistry / methods. Magnetic Resonance Imaging / methods. Male. Middle Aged. Retrospective Studies. S100 Proteins / metabolism. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Rosai-Dorfman disease.
  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16099162.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human; 0 / S100 Proteins
  •  go-up   go-down


77. Jouanneau E, Guzman Tovar RA, Desuzinges C, Frappaz D, Louis-Tisserand G, Sunyach MP, Jouvet A, Sindou M: Very late frontal relapse of medulloblastoma mimicking a meningioma in an adult: usefulness of 1H magnetic resonance spectroscopy and diffusion-perfusion magnetic resonance imaging for preoperative diagnosis: case report. Neurosurgery; 2006 Apr;58(4):E789; discussion E789
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Very late frontal relapse of medulloblastoma mimicking a meningioma in an adult: usefulness of 1H magnetic resonance spectroscopy and diffusion-perfusion magnetic resonance imaging for preoperative diagnosis: case report.
  • OBJECTIVE AND IMPORTANCE: We present a rare case of very long-term medulloblastoma relapse in an adult patient and discuss the pattern of recurrence and metabolic imaging of the tumor.
  • Magnetic resonance images were suggestive of a meningioma.
  • Metabolic imaging favored the diagnosis of medulloblastoma over the initially suspected diagnosis of meningioma.
  • Our observation validates the clinical interest of preoperative metabolic imaging for brain tumors with distinctive pattern.
  • [MeSH-major] Cerebellar Neoplasms / diagnosis. Medulloblastoma / diagnosis. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis

  • Genetic Alliance. consumer health - Medulloblastoma.
  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16575298.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


78. Cha S, Yang L, Johnson G, Lai A, Chen MH, Tihan T, Wendland M, Dillon WP: Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol; 2006 Feb;27(2):409-17
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND PURPOSE: The widely accepted MR method for quantitating brain tumor microvascular permeability, K(trans), is the steady-state T1-weighted gradient-echo method (ssT1).
  • [MeSH-major] Blood Volume / physiology. Blood-Brain Barrier / physiology. Brain / blood supply. Brain Neoplasms / blood supply. Diffusion Magnetic Resonance Imaging / methods. Glioma / blood supply. Image Processing, Computer-Assisted / methods. Magnetic Resonance Angiography / methods. Meningeal Neoplasms / blood supply. Meningioma / blood supply. Potassium / metabolism. Water-Electrolyte Balance / physiology
  • [MeSH-minor] Adolescent. Adult. Aged. Blood Flow Velocity / drug effects. Blood Flow Velocity / physiology. Cohort Studies. Female. Humans. Male. Microcirculation / physiopathology. Middle Aged. Regional Blood Flow / drug effects. Regional Blood Flow / physiology. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Fluid and Electrolyte Balance.
  • MedlinePlus Health Information. consumer health - Potassium.
  • Hazardous Substances Data Bank. POTASSIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] AJNR Am J Neuroradiol. 2006 Feb;27(2):418-9 [16484421.001]
  • (PMID = 16484420.001).
  • [ISSN] 0195-6108
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] RWP5GA015D / Potassium
  •  go-up   go-down


79. Huang SQ, Liang BL, Xie BK, Zhong JL, Zhang Z, Zhang R: [Preliminary application of functional magnetic resonance imaging to neurosurgery]. Ai Zheng; 2006 Mar;25(3):343-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND & OBJECTIVE: Motor functional deficit may be caused by surgery resection of brain tumors around the central sulcus.
  • METHODS: Routine MRI and fMRI were performed on 31 patients with brain tumor around the central sulcus.
  • Of the 31 cases of brain tumor, 10 were metastases, 11 were gliomas, 6 were meningiomas, 2 were arterial-venal malformation (AVM), and 2 were arachnoid cysts. fMRI was performed using FFE-EPI sequence.
  • Other activation areas in different places of brain in individual patients were also appeared.
  • CONCLUSION: fMRI may help to identify the relationship between the brain tumors near central sulcus and the location of motor hand functional cortex, therefore, provide reference for neurosurgery.
  • [MeSH-major] Brain / physiopathology. Brain Neoplasms / diagnosis. Glioma / diagnosis. Magnetic Resonance Imaging
  • [MeSH-minor] Adolescent. Adult. Aged. Arteriovenous Malformations / diagnosis. Arteriovenous Malformations / physiopathology. Child. Female. Hand / physiopathology. Humans. Male. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / physiopathology. Meningioma / diagnosis. Meningioma / physiopathology. Middle Aged. Motor Activity / physiology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16536991.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


80. Nayak L, Abrey LE, Iwamoto FM: Intracranial dural metastases. Cancer; 2009 May 1;115(9):1947-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with concurrent brain or leptomeningeal metastases were excluded.
  • On imaging, 70% had metastases of the overlying skull, 44% had dural tail metastases, 53% had vasogenic edema, and 34% had brain invasion.
  • [MeSH-major] Dura Mater. Meningeal Neoplasms / secondary. Meningioma / secondary
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Disease-Free Survival. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Prognosis. Retrospective Studies. Tomography, X-Ray Computed. Treatment Outcome. Young Adult

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19241421.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Kozler P, Benes V, Netuka D, Kramár F, Charvát F: [Intracranial meningiomas; standard diagnostic procedure and results of surgical treatment]. Rozhl Chir; 2006 Sep;85(9):431-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of the study is to define radiological parameters which may indirectly indicate invasive expansion of a meningioma and thus forecast potential risks of postoperative neurological deficits.
  • The study group includes 40 adult patients in comparable physical conditions (age 18-75, CRS 70-100, ASA 1-2) with meningiomas, affecting the brain tissue only.
  • The results indicate that unfavorable parametres, predicting potential postoperative neurological deficits include: growth of a meningioma in eloquent regions and presence of a peritumoral oedema.
  • Positive parametres, indicating that no neurological deficit would arise, include: dural supply, visible brain-tumor barrier, non-eloquent location of a meningioma and absence of a peritumoral oedema.
  • [MeSH-major] Meningeal Neoplasms / radiography. Meningioma / radiography
  • [MeSH-minor] Adult. Aged. Brain Neoplasms / radiography. Brain Neoplasms / surgery. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17323765.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


82. Shnaper S, Desbaillets I, Brown DA, Murat A, Migliavacca E, Schluep M, Ostermann S, Hamou MF, Stupp R, Breit SN, de Tribolet N, Hegi ME: Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. Int J Cancer; 2009 Dec 1;125(11):2624-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For patients with brain tumors identification of diagnostic and prognostic markers in easy accessible biological material, such as plasma or cerebrospinal fluid (CSF), would greatly facilitate patient management.
  • Determination of MIC-1/GDF15 protein levels by ELISA in the CSF of a cohort of 94 patients with intracranial tumors including gliomas, meningioma and metastasis revealed significantly increased concentrations in glioblastoma patients (median, 229 pg/ml) when compared with control cohort of patients treated for non-neoplastic diseases (median below limit of detection of 156 pg/ml, p < 0.0001, Mann-Whitney test).
  • [MeSH-major] Biomarkers, Tumor / cerebrospinal fluid. Brain Neoplasms / cerebrospinal fluid. Glioblastoma / cerebrospinal fluid. Growth Differentiation Factor 15 / cerebrospinal fluid
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Case-Control Studies. Cohort Studies. Enzyme-Linked Immunosorbent Assay. Female. Humans. Immunoenzyme Techniques. Male. Middle Aged. Prognosis. RNA, Messenger / genetics. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Survival Rate. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Glioblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19521960.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / GDF15 protein, human; 0 / Growth Differentiation Factor 15; 0 / RNA, Messenger
  •  go-up   go-down


83. McIver JI, Scheithauer BW, Atkinson JL: Deep Sylvian fissure chordoid meningioma: case report. Neurosurgery; 2005 Nov;57(5):E1064; discussion E1064
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deep Sylvian fissure chordoid meningioma: case report.
  • OBJECTIVE AND IMPORTANCE: A case of chordoid meningioma originating in the right sylvian fissure is reported.
  • This is the first reported case of a chordoid meningioma without dural attachment arising in the sylvian fissure.
  • A heterogeneously enhancing right frontotemporal mass was identified on magnetic resonance imaging of the brain.
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging / methods. Male. Meningioma. Neurosurgery / methods

  • Genetic Alliance. consumer health - Meningioma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16284544.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Uzüm N, Ataoğlu GA: Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification. Tumori; 2008 May-Jun;94(3):389-97
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: In the present study, 246 cases of meningioma were reclassified according to the WHO 2000 system.
  • The relationship between tumor grade and morphological parameters like pattern, mitotic index, cellularity, pleomorphism, nucleoli, small cell population with high nucleus/cytoplasmic ratio, necrosis and brain invasion was examined.
  • RESULTS: A correlation was found between all morphologic parameters except for brain invasion.
  • [MeSH-major] Biomarkers, Tumor / analysis. Ki-67 Antigen / analysis. Meningeal Neoplasms / chemistry. Meningeal Neoplasms / pathology. Meningioma / chemistry. Meningioma / pathology. Proto-Oncogene Proteins c-bcl-2 / analysis
  • [MeSH-minor] Adult. Aged. Disease-Free Survival. Female. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Kaplan-Meier Estimate. Male. Middle Aged. Predictive Value of Tests. Prognosis. Retrospective Studies. Severity of Illness Index. World Health Organization

  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18705408.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Proto-Oncogene Proteins c-bcl-2
  •  go-up   go-down


85. Elwatidy S: Bifrontal decompressive craniectomy is a life-saving procedure for patients with nontraumatic refractory brain edema. Br J Neurosurg; 2009 Feb;23(1):56-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bifrontal decompressive craniectomy is a life-saving procedure for patients with nontraumatic refractory brain edema.
  • Despite advances in understanding, monitoring, and treatment, the outcome of patients with refractory brain oedema (RBE) remains poor.
  • In this series the author treated 5 adult patients with non traumatic RBE using BDC.
  • The primary pathology was aneurysmal SAH in 2 patients, CNS infection in 2 patients, and one large calcified olfactory groove meningioma.
  • BDC is an effective method of surgical decompression in patients with RBE; the procedure should be performed quickly after clinical deterioration to prevent irreversible secondary brain damage.
  • [MeSH-major] Brain Edema / surgery. Craniotomy / methods. Decompression, Surgical / methods. Intracranial Hypertension / surgery
  • [MeSH-minor] Adult. Brain Diseases / surgery. Female. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Edema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19234910.001).
  • [ISSN] 1360-046X
  • [Journal-full-title] British journal of neurosurgery
  • [ISO-abbreviation] Br J Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


86. Takahashi S, Ohira T, Shido S, Kawase T: Focal hand dystonia cured by removal of clinoid meningioma-case report-. Neurol Med Chir (Tokyo); 2009 Dec;49(12):619-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Focal hand dystonia cured by removal of clinoid meningioma-case report-.
  • A 40-year-old Asian female presented with an unusual case of focal hand dystonia caused by contralateral clinoid meningioma.
  • Magnetic resonance imaging after surgery showed that the compression of the surrounding brain was released.
  • This case shows that secondary focal hand dystonia caused by extra-axial brain tumor can be cured by surgical removal.
  • [MeSH-major] Dystonic Disorders / etiology. Meningeal Neoplasms / pathology. Meningeal Neoplasms / surgery. Meningioma / pathology. Meningioma / surgery. Skull Base Neoplasms / pathology. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Basal Ganglia / pathology. Basal Ganglia / physiopathology. Basal Ganglia Diseases / etiology. Basal Ganglia Diseases / pathology. Basal Ganglia Diseases / physiopathology. Decompression, Surgical / methods. Disease Progression. Female. Hand / innervation. Hand / physiopathology. Humans. Internal Capsule / pathology. Internal Capsule / physiopathology. Magnetic Resonance Imaging. Neoplasm Invasiveness / pathology. Neural Pathways / pathology. Neural Pathways / physiopathology. Neurosurgical Procedures / methods. Sphenoid Bone / pathology. Sphenoid Bone / surgery. Tegmentum Mesencephali / pathology. Tegmentum Mesencephali / physiopathology. Treatment Outcome

  • Genetic Alliance. consumer health - Dystonia.
  • Genetic Alliance. consumer health - Focal Dystonia.
  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20035142.001).
  • [ISSN] 1349-8029
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


87. Wang Y, Gao X, Tang W, Jiang C: Rosai-Dorfman disease isolated to the central nervous system: a report of six cases. Neuropathology; 2010 Apr;30(2):154-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Preoperatively, all the lesions were misdiagnosed as meningioma.
  • [MeSH-major] Brain / pathology. Central Nervous System Diseases / pathology. Histiocytosis, Sinus / pathology. Spinal Cord / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Male. Medical Records. Meningioma / pathology. Middle Aged. Thoracic Vertebrae. Treatment Outcome

  • Genetic Alliance. consumer health - Rosai-Dorfman disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19703267.001).
  • [ISSN] 1440-1789
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


88. Tanaka A: Imaging diagnosis and fundamental knowledge of common brain tumors in adults. Radiat Med; 2006 Jul;24(6):482-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imaging diagnosis and fundamental knowledge of common brain tumors in adults.
  • The most common primary brain tumors in Japanese adults are meningiomas, gliomas, pituitary adenomas, and schwannomas, which together account for 84.0% of all primary brain tumors.
  • The molecular genetic analysis of brain tumors has recently become important.
  • [MeSH-major] Brain Neoplasms / diagnosis. Magnetic Resonance Imaging. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Glioma / diagnosis. Humans. Image Processing, Computer-Assisted. Japan / epidemiology. Meningioma / diagnosis. Neurilemmoma / diagnosis. Pituitary Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 [11895036.001]
  • [Cites] AJNR Am J Neuroradiol. 1993 Sep-Oct;14(5):1241-7 [8237710.001]
  • [Cites] Neuromolecular Med. 2003;3(1):41-52 [12665675.001]
  • [Cites] AJNR Am J Neuroradiol. 1990 Sep-Oct;11(5):935-8 [2120998.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Nov;84(11):3972-82 [10566636.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):65-73 [10924973.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Aug;22(7):1306-15 [11498419.001]
  • [Cites] Radiology. 1999 Nov;213(2):383-8 [10551216.001]
  • [Cites] AJNR Am J Neuroradiol. 1994 Mar;15(3):525-32 [8197952.001]
  • [Cites] Oncogene. 1999 Jul 15;18(28):4144-52 [10435596.001]
  • [Cites] Int J Cancer. 2000 Jan 1;85(1):78-81 [10585587.001]
  • [Cites] J Neurosurg. 1998 Jul;89(1):69-73 [9647174.001]
  • [Cites] J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89 [15977639.001]
  • [Cites] J Neuroimaging. 1996 Apr;6(2):104-7 [8634482.001]
  • [Cites] Radiology. 1990 Aug;176(2):447-50 [2367659.001]
  • [Cites] Neuroradiology. 1997 Aug;39(8):593-8 [9272499.001]
  • [Cites] Surg Neurol. 2002 Dec;58(6):395-402; discussion 402 [12517619.001]
  • [Cites] Radiology. 1997 Apr;203(1):263-7 [9122405.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Mar;21(3):485-8 [10730639.001]
  • [Cites] AJNR Am J Neuroradiol. 1992 Sep-Oct;13(5):1279-91 [1414816.001]
  • [Cites] Radiology. 1994 Apr;191(1):41-51 [8134596.001]
  • [Cites] Cancer. 1975 Jul;36(1):216-20 [1203849.001]
  • [Cites] Nihon Igaku Hoshasen Gakkai Zasshi. 1998 Jun;58(7):349-52 [9711074.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Mar;18(3):551-4 [9090422.001]
  • [Cites] Surg Neurol. 1994 Jun;41(6):486-9 [8059328.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1081-8 [11415902.001]
  • [Cites] Radiology. 2002 Jul;224(1):177-83 [12091680.001]
  • [Cites] Radiology. 2003 Aug;228(2):533-8 [12819334.001]
  • [Cites] Jpn J Clin Oncol. 2001 Oct;31(10):510-3 [11696622.001]
  • (PMID = 16958433.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 31
  •  go-up   go-down


89. Schulder M, Salas S, Brimacombe M, Fine P, Catrambone J, Maniker AH, Carmel PW: Cranial surgery with an expanded compact intraoperative magnetic resonance imager. Technical note. J Neurosurg; 2006 Apr;104(4):611-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the 55 patients who have undergone surgery in the PoleStar N20 device, diagnoses included glioma in 13, meningioma in 12, pituitary adenoma in nine, other skull base lesions in seven, and miscellaneous other diagnoses.
  • [MeSH-major] Brain Diseases / surgery. Brain Neoplasms / surgery. Magnetic Resonance Imaging / instrumentation. Neuronavigation / instrumentation. Point-of-Care Systems. Surgery, Computer-Assisted / instrumentation
  • [MeSH-minor] Adult. Aged. Efficiency. Equipment Design. Female. Humans. Male. Middle Aged. Phantoms, Imaging. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16619667.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


90. Ilhan A, Gartner W, Neziri D, Czech T, Base W, Hörl WH, Wagner L: Angiogenic factors in plasma of brain tumour patients. Anticancer Res; 2009 Feb;29(2):731-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiogenic factors in plasma of brain tumour patients.
  • However, knowledge of the plasma detectability of distinct angiogenic factors in patients with brain tumour is very limited.
  • This study evaluates the plasma concentrations of the angiogenic factors angiopoietin-2 (Ang-2), vascular endothelial growth factor (VEGF) and platelet-derived growth factor BB (PDGF-BB) in patients with brain tumour.
  • PATIENTS AND METHODS: Plasma samples of 78 patients suffering from various types of intracranial tumours (glioblastoma multiforme, GBM, n = 22; astrocytoma, n = 12; meningioma, n = 16; and intracranial metastasis, n = 28) were analysed.
  • RESULTS: Ang-2 plasma concentration in GBM patients was significantly lower when compared with that in patients with meningioma and intracranial metastasis.
  • Highest levels of VEGF concentrations were detected in plasma derived from patients suffering from meningioma.
  • CONCLUSION: The detectability of the angiogenic factors Ang-2 and VEGF, as well as of PDGF-BB, in the plasma of patients suffering from various types of brain tumours is described.
  • [MeSH-major] Angiogenic Proteins / blood. Brain Neoplasms / blood
  • [MeSH-minor] Adult. Aged. Angiopoietin-2 / blood. Astrocytoma / blood. Astrocytoma / pathology. Enzyme-Linked Immunosorbent Assay. Female. Glioblastoma / blood. Glioblastoma / pathology. Humans. Male. Meningioma / blood. Meningioma / pathology. Middle Aged. Platelet-Derived Growth Factor / metabolism. Proto-Oncogene Proteins c-sis. Vascular Endothelial Growth Factor A / blood

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19331229.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Angiogenic Proteins; 0 / Angiopoietin-2; 0 / Platelet-Derived Growth Factor; 0 / Proto-Oncogene Proteins c-sis; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A; 0 / platelet-derived growth factor BB
  •  go-up   go-down


91. Lee KJ, Joo WI, Rha HK, Park HK, Chough JK, Hong YK, Park CK: Peritumoral brain edema in meningiomas: correlations between magnetic resonance imaging, angiography, and pathology. Surg Neurol; 2008 Apr;69(4):350-5; discussion 355
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritumoral brain edema in meningiomas: correlations between magnetic resonance imaging, angiography, and pathology.
  • METHODS: Seventy-nine patients with meningioma were examined by MRI and cerebral angiography.
  • However, in multivariate analyses, pial blood supply was statistically significant as a factor for peritumoral edema in meningioma (P = .029).
  • CONCLUSIONS: In our results, male sex, hyperintensity on T2WI, and pial blood supply were associated with peritumoral edema in meningioma that influence the clinical prognosis of patients.
  • [MeSH-major] Brain Edema / etiology. Meningeal Neoplasms / pathology. Meningeal Neoplasms / radiography. Meningioma / pathology. Meningioma / radiography
  • [MeSH-minor] Adult. Aged. Cerebral Angiography. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Retrospective Studies. Sex Factors. Tumor Burden

  • Genetic Alliance. consumer health - Edema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18262249.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Singleton RH, Kellermier H, Lunsford LD: Radiation-induced meningioma concealed by shunt valve artifact: case report. Neurosurgery; 2008 Mar;62(3):E743-4; discussion E743-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-induced meningioma concealed by shunt valve artifact: case report.
  • We present the case of a radiation-induced meningioma growing around a ventricular catheter that was not noted at an early stage as a result of artifact from an overlying shunt.
  • Her most recent imaging revealed a new meningioma at the edge of the MRI artifact associated with the shunt valve.
  • A contrasted computed tomographic scan demonstrated a large meningioma with mass effect on the surrounding brain.
  • INTERVENTION: Complete surgical resection of the meningioma was obtained.
  • [MeSH-major] Artifacts. Cerebrospinal Fluid Shunts. Magnetic Resonance Imaging / methods. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / etiology. Meningioma / diagnosis. Meningioma / etiology. Neoplasms, Radiation-Induced / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Radiotherapy / adverse effects


93. Amemiya S, Aoki S, Ohtomo K: Cranial nerve assessment in cavernous sinus tumors with contrast-enhanced 3D fast-imaging employing steady-state acquisition MR imaging. Neuroradiology; 2009 Jul;51(7):467-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Brain Neoplasms / pathology. Cavernous Sinus / pathology. Cranial Nerves / pathology. Magnetic Resonance Angiography / methods
  • [MeSH-minor] Adult. Aged. Contrast Media. Female. Gadolinium. Hemangioma / pathology. Humans. Male. Meningioma / pathology. Middle Aged. Neoplasm Metastasis. Pituitary Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 1999 Mar-Apr;23(2):224-31 [10096329.001]
  • [Cites] J Neurosurg. 2007 Nov;107(5):937-44 [17977264.001]
  • [Cites] J Neurosurg. 1976 Aug;45(2):169-80 [939976.001]
  • [Cites] Neurosurg Rev. 2000 Mar;23(1):45-8 [10809487.001]
  • [Cites] Neurol Res. 1998 Oct;20(7):585-92 [9785585.001]
  • [Cites] J Neuroimaging. 2001 Apr;11(2):160-4 [11296586.001]
  • [Cites] Eur Radiol. 2000;10(7):1061-7 [11003398.001]
  • [Cites] Neuroradiology. 1998 Oct;40(10):627-30 [9833890.001]
  • [Cites] J Neurosurg. 1984 Feb;60(2):365-99 [6693964.001]
  • [Cites] Neurosurgery. 1982 Nov;11(5):712-7 [7155338.001]
  • [Cites] Neurosurgery. 2004 Jun;54(6):1385-93; discussion 1393-4 [15157295.001]
  • [Cites] AJNR Am J Neuroradiol. 2005 Apr;26(4):946-50 [15814950.001]
  • [Cites] Clin Neurol Neurosurg. 1988;90(4):311-9 [3233857.001]
  • [Cites] AJNR Am J Neuroradiol. 2005 May;26(5):1128-35 [15891171.001]
  • [Cites] J Magn Reson Imaging. 2006 Nov;24(5):1005-10 [17031835.001]
  • [Cites] J Neurosurg. 1982 Feb;56(2):228-34 [7054432.001]
  • (PMID = 19238368.001).
  • [ISSN] 1432-1920
  • [Journal-full-title] Neuroradiology
  • [ISO-abbreviation] Neuroradiology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media; AU0V1LM3JT / Gadolinium
  •  go-up   go-down


94. Kim NR, Cho SJ, Suh YL: Allelic loss on chromosomes 1p32, 9p21, 13q14, 16q22, 17p, and 22q12 in meningiomas associated with meningioangiomatosis and pure meningioangiomatosis. J Neurooncol; 2009 Sep;94(3):425-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The meningioma portions of MA-Ms showed LOH for loci on chromosomes 22q12, 9p21, and 1p32 in 57.1% (4/7), 28.6% (2/7), and 28.6% (2/7) of cases, respectively.
  • The proliferation indices of MA-Ms were significantly higher in the meningioma than in the MA components.
  • Our data suggest that both the meningioma and the MA undergo the same overlapping clonal process, with the MA-M while undergoing additional genetic alterations that confer a greater proliferative potential.
  • [MeSH-major] Angiomatosis / genetics. Chromosomes, Human / genetics. Loss of Heterozygosity / genetics. Meningeal Neoplasms / genetics. Meningioma / genetics
  • [MeSH-minor] Child. Child, Preschool. Chromosomes, Human, Pair 1. Chromosomes, Human, Pair 11. Chromosomes, Human, Pair 19. Chromosomes, Human, Pair 22. Female. Humans. Male. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Brain Pathol. 2002 Apr;12(2):183-90 [11958372.001]
  • [Cites] Neuropathology. 2006 Jun;26(3):249-56 [16771183.001]
  • [Cites] Eur Neurol. 2003;49(3):184-6 [12646767.001]
  • [Cites] Arch Pathol Lab Med. 1995 Nov;119(11):1061-4 [7487408.001]
  • [Cites] Radiology. 1991 Jun;179(3):819-21 [2027998.001]
  • [Cites] Cancer Res. 1999 Dec 1;59(23):5995-8 [10606247.001]
  • [Cites] Neurosurgery. 2004 Nov;55(5):1163-73 [15509323.001]
  • [Cites] Acta Neuropathol. 1987;73(4):361-4 [3618128.001]
  • [Cites] Am J Surg Pathol. 2002 Jan;26(1):125-9 [11756780.001]
  • [Cites] Am J Pathol. 1995 Apr;146(4):827-32 [7717450.001]
  • [Cites] Br J Neurosurg. 1999 Apr;13(2):167-73 [10616586.001]
  • [Cites] Am J Surg Pathol. 1999 Aug;23(8):872-5 [10435554.001]
  • [Cites] Pediatr Dev Pathol. 2001 Nov-Dec;4(6):568-72 [11826364.001]
  • [Cites] Neuropathol Appl Neurobiol. 2002 Feb;28(1):48-56 [11849563.001]
  • [Cites] Oncogene. 1999 Apr 1;18(13):2231-9 [10327069.001]
  • [Cites] Genomics. 1998 Jun 1;50(2):275-80 [9653655.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] Appl Environ Microbiol. 2001 May;67(5):2354-9 [11319122.001]
  • [Cites] Brain Pathol. 2005 Jan;15(1):55-65 [15779237.001]
  • [Cites] J Neuropathol Exp Neurol. 1997 May;56(5):485-9 [9143261.001]
  • (PMID = 19347254.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


95. Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A: NF2 mutations in secretory and other rare variants of meningiomas. Brain Pathol; 2006 Jan;16(1):15-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To determine whether rare meningioma variants carry NF2 mutations we analyzed 80 tumors.
  • NF2 mutations were detected in 5 (36%) of 14 psammomatous, 1 (11%) of 9 angiomatous, 2 (22%) of 9 clear cell, 1 (33%) of 3 chordoid and 1 (100%) of 1 papillary meningioma.
  • In the single papillary meningioma, 2 different NF2 mutations were observed.
  • No NF2 mutations were found in 33 secretory, 7 microcystic, 2 lymphoplasmacyte-rich, one rhabdoid and one metaplastic meningioma.
  • [MeSH-major] Genes, Neurofibromatosis 2 / physiology. Meningeal Neoplasms / genetics. Meningioma / genetics
  • [MeSH-minor] Adult. Aged. Alternative Splicing / genetics. DNA Mutational Analysis. Female. Humans. Male. Middle Aged. Mutation / physiology. Polymorphism, Single-Stranded Conformational. Reverse Transcriptase Polymerase Chain Reaction

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16612978.001).
  • [ISSN] 1015-6305
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


96. Zada G, Day JD, Giannotta SL: The extradural temporopolar approach: a review of indications and operative technique. Neurosurg Focus; 2008;25(6):E3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A sequential progression of bone removal at the anterior and middle skull base, followed by opening the layers of the lateral wall of the cavernous sinus was next performed to safely retract the brain and widen the exposure to the cavernous sinus, interpeduncular fossa, and upper petroclival regions.
  • The main indications for surgery were as follows: meningioma (25 patients, 38%), basilar artery aneurysm (11 patients, 17%), trigeminal schwannoma (7 patients, 11%), chordoma (5 patients, 7%), hemangioma (3 patients, 5%), pituitary adenoma (3 patients, 5%), superior cerebellar artery aneurysm (3 patients, 5%), and other lesions (9 patients, 14%).
  • Mobilization of the cranial nerves and internal carotid artery allow gentle brain retraction and maximal preservation of venous outflow.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Brain Neoplasms / radiography. Brain Neoplasms / surgery. Cavernous Sinus / radiography. Cavernous Sinus / surgery. Humans. Middle Aged. Retrospective Studies. Temporal Bone / radiography. Temporal Bone / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19035701.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M: Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging; 2006 Oct;24(4):817-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIALS AND METHODS: This study involved 105 patients with lesions (high-grade glioma (N=26), low-grade glioma (N=11), meningioma (N=23), metastasis (N=25), hemangioblastoma (N=6), pyogenic abscess (N=4), schwannoma (N=5), and lymphoma (N=5)).
  • [MeSH-major] Brain Neoplasms / diagnosis. Magnetic Resonance Imaging / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Blood Volume. Cerebrovascular Circulation. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Image Interpretation, Computer-Assisted. Infant. Male. Middle Aged. Statistics, Nonparametric

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16958061.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Char DH, Shiel MJ: Orbital meningioma after cranial radiation for acute lymphocytic leukemia. Orbit; 2008;27(4):321-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Orbital meningioma after cranial radiation for acute lymphocytic leukemia.
  • PURPOSE: To describe the ophthalmic findings of cranial radiation-induced orbital meningioma after acute lymphocytic leukemia therapy.
  • [MeSH-major] Brain Neoplasms / radiotherapy. Cranial Irradiation / adverse effects. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology. Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging. Male

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18716974.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


99. Young JP, Young PH: Meningioma associated with abscess formation--a case report. Surg Neurol; 2005 Jun;63(6):584-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Meningioma associated with abscess formation--a case report.
  • A rare case of meningioma associated with both intratumoral and peritumoral abscess formation occurred in a 38-year-old man presenting with signs and symptoms of elevated intracranial pressure, intracranial infection, and right temporal pole mass lesion.
  • The mass lesion was totally removed, revealing a meningioma.
  • [MeSH-major] Brain Abscess / microbiology. Brain Abscess / pathology. Meningeal Neoplasms / complications. Meningeal Neoplasms / pathology. Meningioma / complications. Meningioma / pathology
  • [MeSH-minor] Adult. Dental Instruments / adverse effects. Dura Mater / pathology. Humans. Male. Neurosurgical Procedures. Oxacillin / therapeutic use. Sphenoid Bone / pathology. Streptococcal Infections / complications. Streptococcal Infections / etiology. Streptococcal Infections / physiopathology. Temporal Lobe / pathology. Treatment Outcome

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15936397.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] UH95VD7V76 / Oxacillin
  •  go-up   go-down


100. Kinoshita M, Goto T, Okita Y, Kagawa N, Kishima H, Hashimoto N, Yoshimine T: Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema. J Neurooncol; 2010 Feb;96(3):409-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The present investigation reevaluated the utility of TII in patients with meningioma or glioma.
  • [MeSH-major] Brain Edema / diagnosis. Brain Neoplasms / diagnosis. Glioma / diagnosis. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis
  • [MeSH-minor] Adult. Aged. Carbon Isotopes. Diffusion Tensor Imaging. Female. Humans. Image Processing, Computer-Assisted. Male. Methionine. Middle Aged. Positron-Emission Tomography / methods. Statistics as Topic. Young Adult

  • Genetic Alliance. consumer health - Edema.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • Hazardous Substances Data Bank. (L)-Methionine .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Cancer Res. 2004 Nov 1;10(21):7163-70 [15534088.001]
  • [Cites] J Nucl Med. 2004 Aug;45(8):1293-8 [15299051.001]
  • [Cites] Neurosurgery. 2006 Apr;58(4 Suppl 2):ONS-292-303; discussion ONS-303-4 [16582653.001]
  • [Cites] J Neurosurg. 2005 Apr;102(4):664-72 [15871509.001]
  • [Cites] Neuroimage. 2008 Jan 1;39(1):369-82 [17911032.001]
  • [Cites] AJNR Am J Neuroradiol. 2003 May;24(5):937-41 [12748097.001]
  • [Cites] J Neurooncol. 2003 Jun;63(2):109-16 [12825815.001]
  • [Cites] J Neurooncol. 2000 Dec;50(3):215-26 [11263501.001]
  • [Cites] Neuroimage. 2005 Apr 1;25(2):424-9 [15784421.001]
  • [Cites] Ann Neurol. 2002 Mar;51(3):377-80 [11891834.001]
  • [Cites] Neuroimage. 2009 Apr 1;45(2):312-8 [19111621.001]
  • [Cites] J Appl Clin Med Phys. 2004 Summer;5(3):66-79 [15753941.001]
  • [Cites] Neuroimage. 2007 Feb 1;34(3):949-56 [17166744.001]
  • [Cites] Neurosurgery. 2005;56(1):130-7; discussion 138 [15617595.001]
  • [Cites] Neuroimage. 2006 May 1;30(4):1219-29 [16364659.001]
  • [Cites] Int J Appl Radiat Isot. 1979 Jul;30(7):393-9 [478664.001]
  • [Cites] Neurology. 1998 May;50(5):1316-22 [9595980.001]
  • [Cites] AJNR Am J Neuroradiol. 2008 Jun;29(6):1176-82 [18388218.001]
  • [Cites] Neuroimage. 2008 Oct 15;43(1):29-35 [18672074.001]
  • [Cites] Radiology. 2004 Jul;232(1):221-8 [15220505.001]
  • [Cites] J Neurosurg. 2007 Jan;106(1):128-33 [17236498.001]
  • [Cites] J Neurosurg. 1995 Oct;83(4):682-9 [7674019.001]
  • [Cites] Radiology. 2004 Aug;232(2):451-60 [15215555.001]
  • [Cites] Neuroimage. 2004 Sep;23(1):46-53 [15325351.001]
  • [Cites] Neurosurgery. 2005 Jan;56(1 Suppl):98-109; discussion 98-109 [15799797.001]
  • [Cites] J Magn Reson B. 1994 Mar;103(3):247-54 [8019776.001]
  • [Cites] Magn Reson Med. 2005 Nov;54(5):1216-25 [16200554.001]
  • [Cites] Radiology. 2006 Apr;239(1):217-22 [16484348.001]
  • [Cites] Neuroimage. 2009 Feb 1;44(3):653-60 [18951985.001]
  • [Cites] J Nucl Med. 2007 Sep;48(9):1468-81 [17704239.001]
  • [Cites] Biophys J. 1994 Jan;66(1):259-67 [8130344.001]
  • (PMID = 19696968.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carbon Isotopes; AE28F7PNPL / Methionine
  •  go-up   go-down






Advertisement